chronic obstructive pulmonary disease: A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
510425 |
3. Check pre-conditions, main-only, mode, registry filtersPre-conditions: EVENT_AGE>=65 Registry filters:
2 out of 7 registries used, show all original rules. |
13897 |
4. Check minimum number of eventsNone |
13897 |
5. Include endpointsNone |
13897 |
6. Filter based on genotype QC (FinnGen only) |
13897 |
Control definitions (FinnGen only)
- Control exclude
- COPD_EARLYANDLATER
- Control pre-conditions
- DEATH_AGE>=65
- Control conditions
- not COPD_EARLY
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J40-J47
- Name in latin
- Alii morbi obstructivi chronici pulmonum
Similar endpoints
↥List of similar endpoints to
Later onset COPD
based on the number of shared cases.
Similar with more cases:
- Later onset COPD, excluding more controls
- Other chronic obstructive pulmonary disease
- COPD, early/later onset
- COPD
- Other chronic obstructive pulmonary disease, including avohilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 114662 | 34294 | 77648 |
| Only index persons | 71526 | 25168 | 46358 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.83 | 0.98 | 2.17 |
| Only index persons | 1.47 | 0.93 | 1.77 |
| Median age at first event (years) | |||
| Whole population | 74.21 | 74.61 | 74.05 |
| Only index persons | 74.02 | 74.33 | 73.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13897 | 2855 | 11042 |
| Unadjusted period prevalence (%) | 4.07 | 0.97 | 4.87 |
| Median age at first event (years) | 73.38 | 72.26 | 73.67 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 7030
- Matched controls
- 65302
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
36.4
323.0
914
267
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.7
323.0
1349
3158
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
34.5
323.0
524
152
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.7
323.0
1766
4350
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
172.8
323.0
2193
171
R06.0
ICD-10 Finland
Dyspnoea
3.4
323.0
3088
12279
C03CA01
ATC
furosemide; systemic
3.0
323.0
3795
18554
R95
ICPC
Chron obstructive pulmonary disease
41.5
323.0
1234
333
I50.9
ICD-10 Finland
Heart failure, unspecified
3.4
323.0
2234
7822
R03AK06
ATC
salmeterol and fluticasone; inhalant
8.1
323.0
2449
4043
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
7.7
323.0
922
1248
R03AC02
ATC
salbutamol; inhalant
7.1
323.0
5431
21155
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
29.2
323.0
454
154
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
257.7
323.0
1574
73
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.2
323.0
3440
12033
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
226.7
323.0
2390
148
J45.9
ICD-10 Finland
Asthma, unspecified
4.8
323.0
2353
6239
R03BB04
ATC
tiotropium bromide; inhalant
36.2
323.0
3935
2212
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
11.5
323.0
660
584
R03AK07
ATC
formoterol and budesonide; inhalant
5.0
323.0
2088
5072
H02AB06
ATC
prednisolone; systemic
4.2
323.0
4853
22618
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
42.7
323.0
847
209
R02
ICPC
Shortness of breath/dyspnoea
3.8
323.0
1716
5137
J96.1
ICD-10 Finland
Chronic respiratory failure
17.4
323.0
547
316
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
534.7
323.0
5947
667
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
7.1
323.0
2978
6151
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
41.3
323.0
745
187
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.4
281.5
941
1826
J43.9
ICD-10 Finland
Emphysema, unspecified
18.5
266.3
429
228
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.4
265.5
1509
4812
R03DA04
ATC
theophylline; systemic, rectal
6.2
260.3
764
1258
N07BA03
ATC
varenicline; oral
10.4
255.4
532
511
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.9
241.3
1144
3121
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.9
232.1
1756
6764
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
227.9
4325
26991
I50.0
ICD-10 Finland
Congestive heart failure
3.4
207.1
1158
3579
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
205.7
1922
8307
J45.1
ICD-10 Finland
Nonallergic asthma
4.3
203.3
840
2001
R03BA02
ATC
budesonide; inhalant
2.9
201.5
1504
5675
R03AC18
ATC
indacaterol; inhalant
47.1
194.7
245
50
R03BA05
ATC
fluticasone; inhalant
2.8
190.1
1485
5738
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.3
181.4
520
818
J01MA14
ATC
moxifloxacin; systemic
3.4
177.7
985
2997
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
177.1
1173
4055
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
175.7
3433
20663
R96
ICPC
Asthma
3.3
166.9
959
2987
SPAT1059
SPAT
Spirometry at the office
4.0
161.7
721
1825
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.9
159.5
479
797
J01AA02
ATC
doxycycline; systemic
2.1
158.0
5510
40997
XG410
NOMESCO Finland
Flow-volume spirometry
4.6
156.9
595
1289
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
156.9
781
2170
J45
ICD-10 Finland
Asthma
3.2
153.7
896
2810
R03BA01
ATC
beclometasone; inhalant
2.7
148.4
1203
4676
R03BB07
ATC
umeclidinium bromide; inhalant
21.5
147.7
225
100
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
44.3
146.3
186
40
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.7
138.0
662
1775
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
133.5
1830
9216
XG466
NOMESCO Finland
Sleep oxymetry
5.0
132.7
456
886
Z72.0
ICD-10 Finland
Tobacco use
8.4
132.4
307
351
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
13.7
131.9
238
167
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.2
131.4
437
818
R03AC12
ATC
salmeterol; inhalant
4.4
129.5
513
1155
R03AC13
ATC
formoterol; inhalant
4.2
128.8
539
1278
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
126.5
861
2982
H02AB07
ATC
prednisone; oral
2.4
123.8
1240
5360
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.9
123.8
871
3079
C07AB07
ATC
bisoprolol; oral
1.8
122.1
4391
31156
R03DC03
ATC
montelukast; oral
2.5
121.3
1073
4338
R03AC03
ATC
terbutaline; inhalant
2.5
120.0
1053
4237
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
14.3
118.9
210
140
R03AK08
ATC
formoterol and beclometasone; inhalant
4.9
117.3
412
818
GD1AD
NOMESCO Finland
Thorax CT examination
3.6
116.7
582
1604
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
10.3
115.6
239
223
J01MA12
ATC
levofloxacin; systemic
2.0
109.5
1739
9178
J45.8
ICD-10 Finland
Mixed asthma
5.3
108.3
352
640
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.2
108.0
357
662
R03BB01
ATC
ipratropium bromide; inhalant
4.3
105.1
418
941
A02BC02
ATC
pantoprazole; systemic
1.8
105.0
4797
35784
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
103.5
2544
15639
R03BB06
ATC
glycopyrronium bromide; inhalant
29.2
99.9
139
45
R04.2
ICD-10 Finland
Haemoptysis
3.7
95.7
456
1205
R03BA08
ATC
ciclesonide; inhalant
2.9
94.9
650
2238
J46
ICD-10 Finland
Status asthmaticus
5.5
94.3
298
524
J01FA06
ATC
roxithromycin; oral
1.7
93.6
2696
17258
A28
ICPC
Limited function/disability NOS
1.9
93.0
1677
9195
348
Kela drug reimbursment
Roflumilast
855.0
90.4
91
*
R03AC19
ATC
olodaterol; inhalant
27.3
89.7
127
44
N02AA05
ATC
oxycodone; systemic
2.0
89.2
1448
7617
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.9
89.1
396
985
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.0
88.8
554
1791
ZXD05
NOMESCO Finland
Urgent procedure
1.7
88.0
2337
14525
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.4
85.8
444
1253
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
6.8
85.0
226
318
C03DA01
ATC
spironolactone; oral
2.1
84.2
1120
5424
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.1
84.2
500
1561
R03AK11
ATC
formoterol and fluticasone; inhalant
5.3
82.8
267
480
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
3.7
82.5
384
993
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.2
81.3
456
1365
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.0
80.4
1211
6157
WX725
NOMESCO Finland
Noninvasive ventilation
3.2
78.8
457
1399
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
78.7
1111
5500
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
10.2
77.8
160
148
SPAT1254
SPAT
Administration of medicine
1.9
77.1
1348
7239
R03DX07
ATC
roflumilast; oral
721.7
76.3
77
*
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.5
75.9
790
12969
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
8.0
75.8
180
214
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
34.0
75.5
101
28
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
75.1
1736
10228
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
74.1
1470
8234
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
8.4
74.1
171
194
R06.2
ICD-10 Finland
Wheezing
3.4
74.0
382
1074
SPAT1058
SPAT
PEF monitoring instruction
2.2
71.1
770
3386
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
10.5
71.0
144
130
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
5.2
70.3
230
421
C01DA14
ATC
isosorbide mononitrate; oral
1.7
69.5
1743
10486
WX892
NOMESCO Finland
Monitored bed care
2.2
69.2
757
3341
XG405
NOMESCO Finland
Education on PEF monitoring
6.4
69.1
192
287
N02AX02
ATC
tramadol; systemic, rectal
1.6
66.8
3071
21657
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
3.6
66.7
325
872
J01CA04
ATC
amoxicillin; systemic
1.6
66.6
5082
40458
130
Kela drug reimbursment
Malignant tumour
2.1
66.2
848
4011
J20
ICD-10 Finland
Acute bronchitis
2.2
65.5
738
3297
Z2446
NOMESCO Finland
Social worker
2.8
64.8
467
1646
J96.0
ICD-10 Finland
Acute respiratory failure
5.8
64.5
192
314
I50.1
ICD-10 Finland
Left ventricular failure
2.5
64.0
551
2152
A46
ICD-10 Finland
Erysipelas
1.8
63.8
1262
7016
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
62.8
2112
13712
R29
ICPC
Respiratory symptom/complaint other
2.6
62.8
501
1877
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
62.7
1150
6227
R28
ICPC
Limited function/disability (R)
5.8
62.6
187
307
R81
ICPC
Pneumonia
3.2
62.1
350
1049
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
61.1
995
5158
WX722
NOMESCO Finland
PEEP
2.6
58.7
456
1681
A06AD11
ATC
lactulose; oral
1.8
57.9
1276
7316
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
57.8
1322
7669
B01AC04
ATC
clopidogrel; oral
1.6
57.7
1710
10689
N05CF01
ATC
zopiclone; oral
1.6
57.6
2348
15913
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
8.1
57.5
135
158
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
4.9
57.5
198
384
C01AA05
ATC
digoxin; systemic
2.0
57.3
854
4277
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
4.1
56.8
234
543
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
3.7
56.8
262
672
P17
ICPC
Tobacco abuse
7.2
56.7
143
187
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
7.0
56.2
145
196
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
55.8
2426
16659
H02AB04
ATC
methylprednisolone; systemic
1.9
55.3
983
5246
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.7
55.0
394
1382
XG460
NOMESCO Finland
Short time oxymetry
4.8
54.9
194
387
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
54.6
2248
15219
J01DA01
ATC
[U] cefalexin; systemic
1.5
54.1
3920
30018
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
53.7
2291
15630
I50
ICD-10 Finland
Heart failure
2.6
53.5
411
1503
R4110
NOMESCO Finland
Physiotherapy
1.6
52.9
1939
12745
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
9.0
52.1
114
119
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.7
52.0
1882
23333
Z3231
NOMESCO Finland
Registered nurse
1.5
51.9
2045
13664
R05
ICPC
Cough
1.6
51.7
1531
9520
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.8
51.6
179
350
J47
ICD-10 Finland
Bronchiectasis
3.8
51.1
228
568
R03BB05
ATC
aclidinium bromide; inhalant
22.7
50.7
75
31
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
10.6
50.3
101
90
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
8.9
50.2
111
118
L28
ICPC
Limited function/disability (L)
1.6
50.2
1414
8666
N06AX11
ATC
mirtazapine; oral
1.5
50.1
1958
13038
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
49.3
760
3841
Z51.5
ICD-10 Finland
Palliative care
2.0
49.0
657
3145
J42
ICD-10 Finland
Unspecified chronic bronchitis
5.6
48.9
148
248
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
48.7
2173
14889
N05CD07
ATC
temazepam; oral
1.8
48.7
1015
5688
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.5
48.4
418
1632
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
7.1
48.0
122
162
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
6.3
47.8
132
197
B01AA03
ATC
warfarin; systemic
1.5
47.3
2019
13680
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
47.1
961
5346
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.5
47.0
1894
12659
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
46.9
1425
18392
J01FF01
ATC
clindamycin; systemic
1.5
46.8
1776
11703
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
5.7
46.8
141
235
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
46.5
2190
15149
GDC00
NOMESCO Finland
Lobectomy of lung
7.7
46.3
111
135
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
10.0
46.2
95
89
R53
ICD-10 Finland
Malaise and fatigue
1.6
46.1
1456
9165
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
9.9
45.9
95
90
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
7.5
45.7
112
141
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
45.6
1014
13993
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
44.9
868
4739
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
6.8
44.5
116
160
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
8.5
44.4
100
110
R60.0
ICD-10 Finland
Localized oedema
1.7
44.3
955
5397
J01DB01
ATC
cefalexin; oral
1.5
43.4
5372
44727
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
11.8
43.4
82
65
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
14.4
43.2
75
49
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.7
42.9
318
1136
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
42.8
405
1656
S97
ICPC
Chronic ulcer skin
2.1
42.6
543
2541
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
4.0
42.3
179
427
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
10.7
42.2
84
74
Z3226
NOMESCO Finland
Physiotherapist
1.6
42.1
1317
8247
I25.2
ICD-10 Finland
Old myocardial infarction
1.8
41.5
727
3833
A07AA02
ATC
nystatin; oral
2.1
41.5
515
2383
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
41.3
1564
10251
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
3.4
40.7
210
590
N05BA04
ATC
oxazepam; oral
1.5
40.5
1516
9898
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
40.4
1067
6382
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
5.5
40.4
125
216
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.9
40.3
648
3314
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
40.0
615
3094
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
39.5
586
2908
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
39.5
2035
14230
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
38.9
459
2077
PE1AT
NOMESCO Finland
Femoral artery PTA
3.7
38.9
179
459
TKC20
NOMESCO Finland
Catheterisation of bladder
1.9
38.8
667
3490
C09AA05
ATC
ramipril; oral
1.4
38.8
2249
16086
G47.3
ICD-10 Finland
Sleep apnoea
1.6
38.8
1336
8546
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.3
38.6
381
1588
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.0
38.4
231
723
J43.8
ICD-10 Finland
Other emphysema
16.4
38.3
63
36
A98
ICPC
Health maint/preventive medicine
0.6
38.3
5770
57318
J43.2
ICD-10 Finland
Centrilobular emphysema
12.4
37.9
70
53
N05AA02
ATC
levomepromazine; systemic
2.8
37.9
255
862
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
37.3
2392
27362
J01FA09
ATC
clarithromycin; systemic
1.5
37.0
1625
10966
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.9
36.1
155
375
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.0
35.6
221
709
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
35.5
1861
13004
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.2
35.5
392
1722
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
35.3
490
2370
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
5.1
35.2
115
212
J96.9
ICD-10 Finland
Respiratory failure, unspecified
7.1
35.0
88
116
N06AB04
ATC
citalopram; systemic
1.5
34.9
1209
7718
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
34.9
1713
11800
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.4
34.7
321
1296
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.7
34.7
1963
22994
N03AX16
ATC
pregabalin; oral
1.5
34.5
1541
10406
TGC00
NOMESCO Finland
Bronchial lavation
2.7
34.5
246
861
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
4.1
34.5
141
327
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
34.3
914
5456
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.3
34.3
347
1464
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.1
33.7
198
611
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.0
33.5
437
2061
AN1
HP
Coronary angiography
1.5
33.5
1230
7950
WX721
NOMESCO Finland
Oxygen concentrator therapy
15.4
33.4
56
34
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
8.7
32.9
73
79
A02BC01
ATC
omeprazole; systemic
1.4
32.9
1931
13744
ZXE00
NOMESCO Finland
One hour or less
1.4
32.9
2546
19039
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
32.6
2387
17676
N05AH04
ATC
quetiapine; oral
1.7
32.5
769
4437
J43
ICD-10 Finland
Emphysema
38.3
31.9
41
10
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
31.6
2809
21448
R79
ICPC
Chronic bronchitis
15.7
31.3
52
31
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
31.3
958
5921
M04AA01
ATC
allopurinol; systemic
1.5
31.2
1213
7926
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
31.2
902
5493
A01AB09
ATC
miconazole; local oral
1.8
31.0
598
3242
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
8.1
30.9
71
82
N05BA01
ATC
diazepam; systemic, rectal
1.6
30.9
832
4977
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
7.8
30.7
72
86
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
30.6
2947
22751
PD3AT
NOMESCO Finland
Pelvic artery PTA
5.3
30.3
95
168
E000001
ATC
NA
1.5
30.3
1181
7721
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.0
30.2
100
188
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.7
30.1
215
752
L57.0
ICD-10 Finland
Actinic keratosis
0.6
30.0
415
6470
WX730
NOMESCO Finland
Conventional respirator
3.4
30.0
153
428
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
30.0
290
1198
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
29.5
1516
10479
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
29.4
787
4693
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
29.4
493
2552
SPAT1060
SPAT
Administration of oxygen
7.5
29.3
71
89
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
6.3
29.3
80
119
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
29.3
4896
41026
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
2.1
29.3
346
1566
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
29.2
1057
6793
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
29.1
1189
7844
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.8
28.9
548
2955
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
8.1
28.8
66
76
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.2
28.5
156
461
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
4.1
28.2
113
258
R50.9
ICD-10 Finland
Fever, unspecified
1.6
28.1
906
5659
SDA02
NOMESCO Finland
Parodonthologic therapy
0.7
28.0
1048
13259
L01CA04
ATC
vinorelbine; systemic
4.5
27.7
102
215
M10.9
ICD-10 Finland
Gout, unspecified
1.7
27.6
627
3570
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
27.6
405
2000
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
27.5
420
2102
K05.31
ICD-10 Finland
Periodontitis pronounced
1.6
27.5
694
4072
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
2.7
27.5
201
717
R05FB02
ATC
cough suppressants and expectorants
1.3
27.3
2414
18289
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.1
27.1
109
250
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.6
26.9
592
8302
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
14.3
26.8
46
30
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.7
26.4
186
648
N02AA01
ATC
morphine; systemic, rectal
3.8
26.4
117
293
PEN23
NOMESCO Finland
Plastic repair of femoral artery
3.6
26.2
121
314
Z2221
NOMESCO Finland
Medical doctor
1.4
26.2
1744
12594
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
10.3
26.1
52
47
J98.1
ICD-10 Finland
Pulmonary collapse
5.2
26.0
82
147
N02BE01
ATC
paracetamol; systemic, rectal
1.4
25.9
5946
51803
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.0
25.8
346
1647
WZC30
NOMESCO Finland
Teaching
1.5
25.8
941
6039
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
6.1
25.8
72
111
R06AE07
ATC
cetirizine; oral
1.3
25.6
2199
16540
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
25.6
336
1589
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.1
25.5
309
1413
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.8
25.4
459
2435
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.4
25.4
95
204
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
5.9
25.1
72
115
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
25.0
2438
18674
TGD00
NOMESCO Finland
Needle biopsy of lung
5.9
25.0
71
112
JN4BD
NOMESCO Finland
Extensive body CT
1.5
24.9
922
5937
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
9.9
24.6
50
47
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.5
24.5
206
794
N05BA02
ATC
chlordiazepoxide; systemic
2.7
24.5
173
603
E0000UV
ATC
NA
1.3
24.5
2312
17613
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
24.3
482
2630
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
24.3
1804
13237
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.7
24.2
1407
16649
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.7
24.2
1459
17170
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
24.1
369
1848
M01AX05
ATC
glucosamine; oral
0.7
24.1
989
12362
207
Kela drug reimbursment
Chronic arrhythmias
1.4
24.1
1437
10157
P01AB01
ATC
metronidazole; oral, rectal
1.3
24.0
2098
15781
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.2
23.9
242
1022
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.7
23.8
107
272
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.5
23.8
778
4864
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.4
23.7
200
772
D82
ICPC
Teeth/gum disease
0.7
23.6
999
12426
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
2.8
23.5
152
503
SPAT1263
SPAT
Sampling
1.3
23.5
2893
22840
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.9
23.5
387
1989
K77
ICPC
Heart failure
2.3
23.5
219
891
K03.64
ICD-10 Finland
Dental calculus supragingival
0.7
23.5
658
8806
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.6
23.4
692
4222
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
23.4
795
5016
A03
ICPC
Fever
1.6
23.2
653
3933
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.5
23.1
892
5786
R04
ICPC
Breathing problem other
2.2
23.1
240
1027
ZX120
NOMESCO Finland
Intravenous
1.6
23.1
641
3847
D19
ICPC
Teeth/gum symptom/complaint
0.7
23.0
668
8889
D07AC01
ATC
betamethasone; topical
1.3
23.0
2153
16338
N05AC02
ATC
thioridazine; oral
3.4
23.0
116
324
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
22.7
520
2965
J92.9
ICD-10 Finland
Pleural plaque without asbestos
3.1
22.5
125
375
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
3.4
22.5
110
300
SPAT1255
SPAT
Intravenous administration of medicine
1.7
22.4
498
2812
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
6.7
22.2
57
79
N19
ICD-10 Finland
Unspecified kidney failure
1.9
22.2
314
1530
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.7
22.1
152
523
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
22.0
958
6368
R33
ICD-10 Finland
Retention of urine
1.5
22.0
735
4613
N07BB01
ATC
disulfiram; oral
2.5
22.0
183
703
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.9
22.0
135
434
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
22.0
1240
8663
PDQ22
NOMESCO Finland
Insertion of endovascular graft into a. iliaca externa
7.6
22.0
52
64
K92.1
ICD-10 Finland
Melaena
1.7
21.9
444
2443
Z02.7
ICD-10 Finland
Issue of medical certificate
1.8
21.8
389
2051
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.2
21.7
233
1012
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
21.7
741
4675
A41.9
ICD-10 Finland
Sepsis, unspecified
2.0
21.6
288
1368
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
21.6
586
7903
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
21.5
349
1787
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
21.3
1207
8430
A02BA04
ATC
nizatidine; systemic
1.6
21.3
542
3177
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
21.3
297
1439
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
2.2
21.2
222
955
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
21.2
217
925
AA1AD
NOMESCO Finland
CT of head and brain
1.3
21.1
1905
14337
S72.0
ICD-10 Finland
Fracture of neck of femur
1.9
21.0
312
1545
A10BA02
ATC
metformin; oral
1.3
21.0
2198
16893
R84
ICPC
Malignant neoplasm bronchus/lung
5.6
20.9
62
104
J94.8
ICD-10 Finland
Other specified pleural conditions
2.6
20.7
158
579
J43.1
ICD-10 Finland
Panlobular emphysema
29.0
20.7
28
9
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
2.1
20.7
232
1028
A04
ICPC
Weakness/tiredness general
1.5
20.6
873
5770
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
20.5
341
1758
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
20.4
1926
14580
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
3.5
20.4
97
260
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
9.1
20.4
43
44
GX2C5
NOMESCO Finland
Short-lasting oximetry
17.6
20.3
32
17
WX882
NOMESCO Finland
High dependency care
2.2
20.3
216
937
A02BA02
ATC
ranitidine; systemic
1.4
20.3
1340
9602
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.7
20.3
89
223
J86.9
ICD-10 Finland
Pyothorax without fistula
3.8
20.2
88
219
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
20.1
1344
9644
J01MA02
ATC
ciprofloxacin; systemic
1.3
20.0
2723
21631
M05BA04
ATC
alendronic acid; oral
1.5
19.9
636
3949
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.7
19.8
134
459
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
19.7
194
813
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
6.8
19.6
50
69
N06AB03
ATC
fluoxetine; oral
1.5
19.6
621
3851
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
4.8
19.5
66
129
N05AX08
ATC
risperidone; systemic
1.7
19.5
466
2690
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.7
19.4
693
8907
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
4.2
19.3
74
164
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
1.7
19.3
432
2446
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
19.3
2060
15838
SPAT1057
SPAT
Peak expiratory flow measurement
2.4
19.2
163
634
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
3.5
19.2
92
248
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
3.0
19.2
112
349
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
19.2
2403
18861
P15
ICPC
Chronic alcohol abuse
2.8
19.1
122
403
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.5
19.0
597
3688
A02BC03
ATC
lansoprazole; oral
1.3
19.0
1877
14263
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
19.0
530
3183
C10AA01
ATC
simvastatin; oral
1.3
18.9
3839
31931
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.9
18.9
283
1407
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
18.9
2116
16361
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
18.8
321
1672
V03AA01
ATC
NA
3.0
18.8
110
344
N06AX16
ATC
venlafaxine; oral
1.6
18.7
487
2872
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
4.1
18.7
73
165
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
7.9
18.7
43
51
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
3.5
18.7
90
244
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.6
18.7
480
2821
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
6.9
18.7
47
64
WX872
NOMESCO Finland
Intensive care
1.7
18.6
412
2325
PEF25
NOMESCO Finland
Thrombendarterectomy of superficial femoral artery
4.2
18.6
72
162
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.7
18.5
693
8844
M54.5
ICD-10 Finland
Low back pain
1.3
18.5
1734
13076
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.2
18.5
196
849
R63.4
ICD-10 Finland
Abnormal weight loss
1.9
18.5
268
1317
Z01.2
ICD-10 Finland
Dental examination
0.8
18.4
1398
16058
E87.6
ICD-10 Finland
Hypokalaemia
2.0
18.3
225
1038
PDQ20
NOMESCO Finland
Insertion of endovascular graft into common iliac artery
4.6
18.3
64
130
R05CB01
ATC
acetylcysteine; inhalant, oral
2.9
18.3
112
361
PD1AE
NOMESCO Finland
Ultrasound examination of abdominal aortta
3.4
18.2
89
244
TUPKY
NOMESCO Finland
NA
6.8
18.2
46
63
W19
ICD-10 Finland
Unspecified fall
1.5
18.2
593
3698
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
18.0
535
3259
J01FA15
ATC
telithromycin; oral
1.6
18.0
445
2586
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.6
18.0
81
208
WF004
NOMESCO Finland
Palliative radiotherapy
2.2
17.9
176
737
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
3.9
17.9
74
177
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
3.7
17.8
78
196
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
3.6
17.7
80
206
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
5.1
17.7
56
102
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
10.2
17.7
35
32
ZXA00
NOMESCO Finland
Right side
1.3
17.7
1912
14684
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
17.7
414
2375
ZXD35
NOMESCO Finland
Usual procedure
2.0
17.7
228
1073
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.8
17.6
310
1630
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
4.8
17.6
59
115
PGH47
NOMESCO Finland
Bypass from femoral to contralateral femoral artery
6.7
17.6
45
63
R39
ICPC
Respiratory, Physical function test
4.8
17.5
58
112
N05AF05
ATC
zuclopenthixol; systemic
4.8
17.5
58
112
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.4
17.4
153
605
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
12.6
17.4
31
23
S22.3
ICD-10 Finland
Fracture of rib
1.6
17.3
449
2644
B01AF02
ATC
apixaban; oral
1.4
17.3
895
6134
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.8
17.2
290
1504
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
17.1
647
4167
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
4.5
17.1
61
127
K07
ICPC
Swollen ankles/oedema
1.7
17.0
366
2048
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
21.2
17.0
25
11
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.8
17.0
113
384
A10BH05
ATC
linagliptin; oral
1.6
16.9
424
2475
UDQ22
NOMESCO Finland
Microlaryngoscopy
3.8
16.9
72
177
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
16.9
304
1612
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
8.4
16.9
37
41
SPAT1153
SPAT
Removal of sutures
0.8
16.8
1790
19775
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.6
16.7
422
2469
I95.9
ICD-10 Finland
Hypotension, unspecified
2.5
16.6
129
477
M79.6
ICD-10 Finland
Pain in limb
1.3
16.6
2127
16663
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.1
16.6
189
847
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.1
16.5
186
829
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
16.5
217
1030
SAA01
NOMESCO Finland
Simple examination of mouth
0.8
16.4
3014
31429
8000/3-C34.1
ICD-O-3
Neoplasm, malignant of upper lobe, lung
11.7
16.3
30
24
F17.1
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, harmful use
23.8
16.2
23
9
E66.9
ICD-10 Finland
Obesity, unspecified
2.3
16.2
149
606
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
+∞
16.2
16
*
J18
ICD-10 Finland
Pneumonia, organism unspecified
3.5
16.1
75
199
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
5.7
15.9
46
76
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.8
15.9
270
1406
XPX00
NOMESCO Finland
Intraoperative angiography
4.4
15.9
58
124
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
2.5
15.9
128
486
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
15.9
452
2730
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
11.8
15.8
29
23
E86
ICD-10 Finland
Volume depletion
2.1
15.8
185
838
R05
ICD-10 Finland
Cough
1.3
15.7
1204
8787
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.7
15.7
726
8971
J41.0
ICD-10 Finland
Simple chronic bronchitis
4.2
15.7
59
130
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
3.6
15.5
71
186
B01AB05
ATC
enoxaparin; parenteral
1.3
15.5
2171
17156
PDP20
NOMESCO Finland
Percutaneous plastic repair of common iliac artery
6.5
15.5
40
57
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
15.5
1881
14613
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.0
15.5
89
276
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.0
15.4
90
282
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
15.3
506
3163
N05AF03
ATC
chlorprothixene; systemic
2.6
15.3
114
413
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
5.5
15.3
45
76
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.8
15.3
251
1291
I70
ICD-10 Finland
Atherosclerosis
4.1
15.3
60
138
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.7
15.3
437
5858
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
15.2
2441
19582
PDQ05
NOMESCO Finland
Insertion of endovascular graft into infrarenal abdominal aorta
2.9
15.2
94
306
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.3
15.1
136
548
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
2.0
15.1
187
868
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
3.8
15.1
63
153
XQ800
NOMESCO Finland
Prick test
1.8
15.1
244
1251
PD5BD
NOMESCO Finland
Extensive CT of aorta
2.0
15.1
182
836
N30.0
ICD-10 Finland
Acute cystitis
1.4
15.0
806
5555
PEF24
NOMESCO Finland
Thrombendarterectomy of deep femoral artery
3.9
14.9
62
150
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.1
14.9
167
743
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
2.7
14.9
102
355
PEN24
NOMESCO Finland
Plastic repair of deep femoral artery
4.5
14.9
52
107
SPAT1262
SPAT
Handing over of treatment supplies
1.3
14.9
1397
10489
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.8
14.8
266
1410
GX2D5
NOMESCO Finland
Sleep oximetry
7.4
14.8
35
44
K28
ICPC
Limited function/disability (K)
2.0
14.8
195
927
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
14.7
995
7118
C08CA01
ATC
amlodipine; oral
1.2
14.7
2889
23664
TGA30
NOMESCO Finland
Thoracocentesis
3.1
14.7
80
240
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
14.6
565
3651
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.7
14.6
336
1916
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
14.6
333
1897
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.8
14.6
92
305
R04.0
ICD-10 Finland
Epistaxis
1.5
14.5
568
3683
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
14.5
229
1163
WF049
NOMESCO Finland
Radiotherapy of metastasis
1.8
14.5
259
1372
WW200
SPAT
NA
0.6
14.4
194
3059
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
8.1
14.3
32
37
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
3.0
14.3
82
254
D07AB08
ATC
desonide; topical
1.5
14.3
580
3790
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
14.3
250
1317
L29.9
ICD-10 Finland
Pruritus, unspecified
2.2
14.2
143
607
SPAT1104
SPAT
Monitoring of emergency patient
1.5
14.2
465
2901
N05AH03
ATC
olanzapine; systemic
1.9
14.2
213
1062
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
3.3
14.2
71
201
J93.8
ICD-10 Finland
Other pneumothorax
4.2
14.1
53
117
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
14.1
468
2927
ZPB22
NOMESCO Finland
Autograft of vein
3.5
14.0
65
173
F17.22
ICD-10 Finland
Addiction-related addiction currently uses controlled substitution treatment
12.3
14.0
25
19
F10.24
ICD-10 Finland
Alcohol depence active use
3.5
14.0
64
169
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
13.9
1212
8995
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.8
13.9
2257
23978
PDH54
NOMESCO Finland
Bypass from aorta to bilateral femoral arteries
6.5
13.9
36
52
S82
ICPC
Naevus/mole
0.7
13.9
380
5138
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
3.9
13.8
56
133
E000003
ATC
NA
1.8
13.8
229
1183
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
13.8
495
3149
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.6
13.8
347
2028
N18.8
ICD-10 Finland
Other chronic renal failure
1.8
13.8
231
1199
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
2.0
13.8
175
823
S12
ICPC
Insect bite/sting
0.6
13.8
236
3512
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
13.7
2118
16865
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
4.5
13.7
48
99
L01CB01
ATC
etoposide; systemic
4.5
13.7
48
99
K02.1
ICD-10 Finland
Caries of dentine
0.8
13.7
2190
23308
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
2.1
13.7
151
669
G03DC02
ATC
norethisterone; oral
0.6
13.6
163
2650
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
2.5
13.6
104
385
SPF30
NOMESCO Finland
Soling for prothesis
2.0
13.6
173
811
N81.1
ICD-10 Finland
Cystocele
0.5
13.6
116
2074
A08
ICPC
Swelling
1.7
13.6
306
1738
RS221
NOMESCO Finland
NA
2.8
13.5
84
276
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.0
13.4
161
740
DQA10
NOMESCO Finland
Biopsy of larynx
3.9
13.4
54
128
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.2
13.4
70
205
R13
ICD-10 Finland
Dysphagia
1.5
13.3
437
2726
XX3DW
NOMESCO Finland
Time consuming IT work
1.4
13.3
704
4832
29599
ICD-8 Finland
Schizophrenia, Unspecified type
5.0
13.3
42
78
A10AE04
ATC
insulin glargine; parenteral
1.4
13.3
634
4275
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
2.7
13.2
92
324
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
2.1
13.2
150
674
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
+∞
13.2
13
*
WW200
NOMESCO Finland
Immunization
2.0
13.1
159
734
Z02.4
ICD-10 Finland
Examination for driving licence
0.8
13.1
1701
18515
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
13.1
301
1717
R78
ICPC
Acute bronchitis/bronchiolitis
2.2
13.1
138
601
D07AC13
ATC
mometasone; topical
1.3
13.0
1615
12533
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
9.7
13.0
26
25
49300
ICD-8 Finland
Asthma, bronchiale
2.1
13.0
147
660
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
13.0
2315
18697
N06AX12
ATC
bupropion; oral
2.3
13.0
121
497
X57
ICD-10 Finland
Unspecified privation
2.1
13.0
139
609
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.8
12.9
1023
11775
T90
ICPC
Diabetes non-insulin dependent
1.2
12.9
1782
13996
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.2
12.9
136
590
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.1
12.9
141
622
F34.1
ICD-10 Finland
Dysthymia
2.3
12.9
121
499
I20.09
ICD-10 Finland
Unstable angina
1.5
12.9
472
3018
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
1.8
12.9
219
1143
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.1
12.8
145
650
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.9
12.8
186
920
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.6
12.8
333
1968
N05BB01
ATC
hydroxyzine; systemic
1.6
12.7
301
1733
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
8.2
12.7
28
32
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
2.3
12.6
113
455
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.6
12.6
227
3341
R24
ICPC
Haemoptysis
3.4
12.6
60
164
SPAT1172
SPAT
Guidance concerning hydration
1.8
12.6
198
1009
WF002
NOMESCO Finland
Radical radiotherapy
1.5
12.6
448
2848
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
3.0
12.6
73
230
JN4AD
NOMESCO Finland
Body CT examination
1.4
12.5
587
3940
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.1
12.5
67
200
30041
ICD-8 Finland
Neuroses, Depressiva
2.5
12.5
97
363
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
12.5
1342
10226
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
4.6
12.5
43
88
XPX08
NOMESCO Finland
Intraoperative flow measurement
2.7
12.5
86
301
R03CC02
ATC
salbutamol; systemic
2.2
12.5
126
539
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
12.5
1298
9852
A02BC05
ATC
esomeprazole; systemic
1.2
12.4
2379
19339
N06AX03
ATC
mianserin; oral
1.7
12.4
267
1498
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.7
12.3
262
1464
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
0.7
12.2
663
8025
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
3.9
12.2
49
116
B01AC07
ATC
dipyridamole; systemic
1.5
12.2
366
2237
N06AB06
ATC
sertraline; oral
1.5
12.2
384
2376
J01DA06
ATC
[U] cefuroxime; systemic
1.4
12.2
695
4830
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
12.2
1398
10733
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
3.0
12.2
70
218
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
12.2
224
1199
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
4.9
12.2
39
74
J15.8
ICD-10 Finland
Other bacterial pneumonia
3.3
12.2
61
174
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
1.9
12.1
172
843
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.5
12.1
96
365
SPAT1216
SPAT
Assessment of functional ability
1.3
12.1
1221
9227
E66.8
ICD-10 Finland
Other obesity
2.0
12.1
155
730
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
12.1
499
3269
RK250
NOMESCO Finland
NA
4.4
12.1
43
91
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
2.6
12.1
88
319
K55.8
ICD-10 Finland
Other vascular disorders of intestine
4.0
12.1
48
113
I73.9
ICD-10 Finland
Peripheral vascular disease, unspecified
2.8
12.0
79
268
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
0.7
12.0
276
3859
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
12.0
253
1412
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.5
11.9
55
147
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.8
11.9
76
255
I71.3
ICD-10 Finland
Abdominal aortic aneurysm, ruptured
3.1
11.9
63
187
R03DC01
ATC
zafirlukast; oral
2.4
11.9
102
401
R99
ICPC
Respiratory disease other
2.2
11.9
114
477
SPAT1234
SPAT
Support of social functional capacity
1.5
11.8
367
2262
GBB00
NOMESCO Finland
Tracheostomy
2.5
11.8
89
328
N05AB03
ATC
perphenazine; systemic, rectal
1.9
11.8
161
777
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.3
11.8
105
424
GEA00
NOMESCO Finland
Mediastinoscopy
4.7
11.8
39
77
N06AA09
ATC
amitriptyline; systemic
1.4
11.8
567
3829
R11
ICD-10 Finland
Nausea and vomiting
1.5
11.7
428
2736
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
11.7
418
2660
PDG05
NOMESCO Finland
Operation on infrarenal abdominal aorta for aneurysm
3.9
11.7
47
112
SPAT1231
SPAT
Assessment of adjustments needed in living environment
1.9
11.7
175
877
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.0
11.7
139
638
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
11.7
1210
9172
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.4
11.6
577
3917
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
7.8
11.6
26
31
D09AB01
ATC
zinc bandage without supplements; topical
2.0
11.5
138
636
N05AB01
ATC
dixyrazine; systemic
2.7
11.5
76
260
E87.5
ICD-10 Finland
Hyperkalaemia
2.1
11.5
133
604
J93.9
ICD-10 Finland
Pneumothorax, unspecified
4.0
11.5
45
105
N03AG01
ATC
valproic acid; systemic, rectal
1.7
11.5
250
1408
R03BB02
ATC
oxitropium bromide; inhalant
4.3
11.5
42
92
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
0.8
11.5
757
8923
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
5.7
11.4
32
52
WX002
NOMESCO Finland
Sedation and analgesia
1.3
11.4
1341
10315
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
11.4
1556
12176
N06AB10
ATC
escitalopram; oral
1.4
11.4
688
4825
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
11.4
459
2997
81
HP
Angiography of the heart and coronary arteries
1.4
11.4
580
3956
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
11.3
1334
10266
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
2.8
11.3
71
236
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.3
11.3
962
7104
A01AB04
ATC
amphotericin B; local oral
1.6
11.3
291
1717
D07XC01
ATC
betamethasone, combinations; topical
1.3
11.3
713
5039
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
5.6
11.3
32
53
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.5
11.3
386
2434
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
11.3
1772
14081
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
3.5
11.3
51
135
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
2.3
11.2
98
391
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
27.9
11.2
15
5
K92.0
ICD-10 Finland
Haematemesis
1.9
11.2
158
774
ZPB40
NOMESCO Finland
Polytetrafluoroethylene
4.3
11.1
40
86
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
3.7
11.1
48
122
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.7
11.1
48
122
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
2.7
11.1
74
255
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.0
11.1
64
202
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
1.8
11.0
188
983
A69.2
ICD-10 Finland
Lyme disease
0.5
11.0
104
1799
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.2
11.0
115
499
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
11.0
521
3508
F05.9
ICD-10 Finland
Delirium, unspecified
2.0
11.0
144
687
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
1.7
10.9
233
1304
PD3BT
NOMESCO Finland
Pelvic artery extensive PTA
5.0
10.9
34
63
F20.0
ICD-10 Finland
Paranoid schizophrenia
4.9
10.9
35
67
ZXA05
NOMESCO Finland
Left side
1.2
10.9
1752
13947
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.7
10.9
74
259
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
4.0
10.9
42
97
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.6
10.8
306
1847
GD2SN
NOMESCO Finland
Lung ventilation SPECT
2.9
10.8
63
200
UJF32
NOMESCO Finland
Coloscopy
1.2
10.8
1793
14317
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.3
10.8
751
5387
2953E
ICD-9 Finland
Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]
6.6
10.8
27
38
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.4
10.8
87
335
BC1AD
NOMESCO Finland
CT of adrenal glands
2.9
10.8
63
201
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
10.7
684
4840
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
2.8
10.7
69
234
VALMI
NOMESCO Finland
NA
0.8
10.7
694
8207
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
10.7
1320
10206
A10BB12
ATC
glimepiride; oral
1.4
10.7
595
4120
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
1.7
10.7
201
1086
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
4.7
10.6
35
69
PEU85
NOMESCO Finland
Plastic repair of bypass from femoral to popliteal artery
11.8
10.6
19
15
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
10.6
363
2294
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.4
10.6
85
327
R41.0
ICD-10 Finland
Disorientation, unspecified
1.7
10.5
219
1217
PD4BD
NOMESCO Finland
Extensive CT of lower extremity arteries
3.3
10.5
52
148
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.1
10.5
117
525
PEN25
NOMESCO Finland
Plastic repair of superficial femoral artery
3.8
10.5
43
105
PDP22
NOMESCO Finland
Percutaneous plastic repair of a. iliaca externa
6.3
10.4
27
40
N05AH02
ATC
clozapine; systemic
3.7
10.4
45
115
N06AA12
ATC
doxepin; systemic
1.5
10.4
307
1872
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
3.4
10.3
49
135
NFQ20
NOMESCO Finland
Amputation of femur
2.6
10.3
73
261
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.6
10.3
74
269
Z72.1
ICD-10 Finland
Alcohol use
2.9
10.3
62
203
D07AA02
ATC
hydrocortisone; topical
1.4
10.3
621
4359
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.6
10.3
136
2148
R43
ICPC
Respiratory, Other diagnostic procedure
3.0
10.2
59
186
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
4.3
10.2
37
81
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
0.5
10.2
75
1395
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
6.4
10.2
26
38
N03AF01
ATC
carbamazepine; oral, rectal
1.6
10.2
285
1720
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
0.6
10.1
197
2852
N04AA02
ATC
biperiden; systemic
2.4
10.1
86
341
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
10.1
423
2782
L75
ICPC
Fracture: femur
2.2
10.1
96
402
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.6
10.1
271
1617
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
4.4
10.0
35
74
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.9
10.0
143
707
N81.6
ICD-10 Finland
Rectocele
0.6
10.0
113
1859
WW500
NOMESCO Finland
Blood transfusion
1.6
10.0
253
1488
1420
FHL
Laryngomicroscopy
2.9
9.9
59
191
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.9
9.9
58
186
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.0
9.9
57
180
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.1
9.9
109
485
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.4
9.9
482
3263
EBA30
NOMESCO Finland
Excision of root of tooth
1.5
9.8
332
2089
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
2.5
9.8
75
282
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.2
9.8
97
414
N05AD01
ATC
haloperidol; systemic
1.8
9.8
162
842
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.5
9.7
288
1760
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.2
9.7
91
380
N17.8
ICD-10 Finland
Other acute renal failure
2.4
9.6
82
325
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
6.6
9.6
24
34
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
9.6
579
4057
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
3.6
9.6
42
109
P29
ICPC
Psychological sympt/compl other
1.9
9.6
140
698
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.6
9.6
225
1299
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.6
9.6
218
1245
HMAK
NOMESCO Finland
NA
0.7
9.6
282
3764
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
9.6
925
6935
G03AC03
ATC
levonorgestrel; systemic
0.4
9.6
50
1044
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
1.9
9.6
131
637
PDG52
NOMESCO Finland
Bypass from aorta to iliac and contralateral femoral artery for aneurysm
10.5
9.6
18
16
5CM18
NOMESCO Finland
NA
3.6
9.5
41
105
K02.0
ICD-10 Finland
Caries limited to enamel
0.6
9.5
199
2836
D05AX52
ATC
calcipotriol, combinations; topical
1.5
9.5
284
1739
XP60W
NOMESCO Finland
NA
5.1
9.5
29
53
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.0
9.5
116
540
N06AX21
ATC
duloxetine; oral
1.4
9.5
416
2762
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
9.5
767
5619
PD7ZT
NOMESCO Finland
Stent grafting of abdominal aorta
2.7
9.5
61
208
A10BH01
ATC
sitagliptin; oral
1.3
9.5
696
5028
N02AC04
ATC
dextropropoxyphene; oral
1.6
9.5
243
1434
L30.3
ICD-10 Finland
Infective dermatitis
1.7
9.5
192
1064
ZZA00
NOMESCO Finland
Split skin graft
1.7
9.5
200
1119
53299
ICD-8 Finland
Ulcer of duodenum, Other and unspecified
3.6
9.4
41
106
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.4
9.4
405
2678
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.2
9.4
1137
8758
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.6
9.4
264
1596
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
11.3
9.4
17
14
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.7
9.4
194
1079
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
0.7
9.4
259
3493
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
9.3
194
1082
R05DB20
ATC
other cough suppressants - combinations
1.6
9.3
268
1626
G20
ICD-10 Finland
Parkinson disease
0.5
9.3
99
1657
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
3.1
9.3
49
147
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
9.3
683
4934
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
3.2
9.3
47
137
L15
ICPC
Knee symptom/complaint
0.8
9.3
865
9804
N05CD02
ATC
nitrazepam; oral
2.0
9.3
119
567
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.4
9.2
439
2962
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
9.2
820
6087
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.4
9.2
363
2364
SPAT1251
SPAT
Organisation of medication
1.6
9.2
240
1426
RK320
NOMESCO Finland
NA
2.7
9.2
62
217
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
1.9
9.1
136
684
F32.1
ICD-10 Finland
Moderate depressive episode
2.0
9.1
113
530
K08.3
ICD-10 Finland
Retained dental root
1.4
9.1
406
2703
WX212
NOMESCO Finland
Femoral plexus blockade
1.9
9.0
129
638
R10.0
ICD-10 Finland
Acute abdomen
1.8
9.0
152
794
Z57.2
ICD-10 Finland
Occupational exposure to dust
3.3
9.0
43
120
PEP25
NOMESCO Finland
Percutaneous plastic repair of superficial femoral artery
3.7
9.0
38
96
L90
ICPC
Osteoarthrosis of knee
0.7
9.0
213
2959
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
1.8
9.0
159
844
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
9.0
998
7611
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.5
9.0
73
1316
ZXD00
NOMESCO Finland
Emergency procedure
1.7
9.0
180
992
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
3.1
9.0
48
146
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.7
9.0
37
92
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.4
8.9
458
3127
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
2.2
8.9
88
375
I72.4
ICD-10 Finland
Aneurysm and dissection of artery of lower extremity
3.0
8.9
51
161
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
4.5
8.9
30
62
M10.2
ICD-10 Finland
Drug-induced gout
4.1
8.8
33
75
XQ845
NOMESCO Finland
Dermatoscopy
0.3
8.8
17
539
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.4
8.8
398
2660
29530
ICD-8 Finland
Schizophrenia, Paranoid type
4.0
8.8
34
80
GD1UN
NOMESCO Finland
Lung circulation SPECT
2.8
8.8
55
183
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
1.9
8.8
117
567
B01AB10
ATC
tinzaparin; parenteral
1.4
8.7
427
2891
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
6.4
8.7
22
32
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.6
8.7
213
1244
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.4
8.7
513
3583
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.2
8.7
89
385
T08
ICPC
Weight loss
2.1
8.7
91
397
RS222
NOMESCO Finland
NA
2.3
8.7
76
307
PG1DM
NOMESCO Finland
Very extensive MRI examination of vasculature not elsewhere classified with 3 Tesla magnet
4.7
8.7
28
55
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
1.8
8.7
132
669
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
8.7
217
1275
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.7
8.6
173
955
D06BB10
ATC
imiquimod; topical
0.6
8.6
118
1849
PDG51
NOMESCO Finland
Bypass from aorta to iliac artery for aneurysm
3.3
8.6
42
120
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.4
8.6
421
2853
L89
ICD-10 Finland
Decubitus ulcer and pressure area
1.9
8.6
119
582
A06AH03
ATC
naloxegol; oral
2.3
8.6
80
332
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
0.6
8.6
113
1787
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
6.2
8.6
22
33
NHQ40
NOMESCO Finland
Amputation of toe
1.9
8.6
123
611
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
7.7
8.6
19
23
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.4
8.5
382
2549
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
2.3
8.5
74
296
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
8.5
594
4259
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
1.9
8.5
113
547
PD1CD
NOMESCO Finland
Very extensive CT of abdominal aorta and branches
3.3
8.5
41
116
L40.9
ICD-10 Finland
Psoriasis, unspecified
2.2
8.5
86
373
I20.00
ICD-10 Finland
Unstable angina
1.5
8.5
245
1491
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
8.5
2191
18141
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.8
8.5
661
7652
A01
ICPC
Pain general/multiple sites
1.4
8.5
431
2939
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
2.7
8.5
55
190
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.5
8.4
48
969
1CX08
NOMESCO Finland
NA
3.2
8.4
42
122
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.8
8.4
145
767
GX1K5
NOMESCO Finland
Diffusion capacity
6.0
8.4
22
34
S10
ICPC
Boil/carbuncle
1.5
8.4
291
1845
9128
FHL
Open reduction and osteosynthesis
1.8
8.4
150
803
E66
ICD-10 Finland
Obesity
1.8
8.4
131
670
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
3.8
8.4
34
84
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
4.0
8.3
32
75
P72
ICPC
Schizophrenia
2.7
8.3
54
186
D02AE01
ATC
carbamide; topical
1.4
8.3
335
2189
F20.5
ICD-10 Finland
Residual schizophrenia
3.7
8.3
35
89
ZY010
NOMESCO Finland
Hospital outpatient
1.8
8.3
144
763
R03
ICPC
Wheezing
2.4
8.3
70
277
P99
ICPC
Psychological disorders other
2.4
8.3
68
267
N05BE01
ATC
buspirone; oral
1.9
8.3
117
578
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
2.0
8.3
104
490
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
1.8
8.3
136
706
D05BB02
ATC
acitretin; oral
1.9
8.3
121
606
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
3.2
8.3
42
124
S01.0
ICD-10 Finland
Open wound of scalp
1.4
8.2
445
3067
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
1.8
8.2
130
668
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
4.3
8.2
29
63
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
1.8
8.2
139
731
S01ED51
ATC
timolol, combinations; ophthalmic
0.7
8.2
337
4254
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
1.5
8.2
259
1609
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
4.4
8.2
28
59
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.1
8.2
90
404
ZX050
NOMESCO Finland
Stereotactic radiotherapy
2.5
8.2
60
222
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.7
8.2
246
3266
F17.3
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, withdrawal state
10.7
8.2
15
13
280
Kela drug reimbursment
Clopidogrel
1.8
8.1
133
690
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
2.3
8.1
70
282
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
1.8
8.1
127
651
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.1
8.1
90
407
B03BA03
ATC
hydroxocobalamin; parenteral
1.4
8.1
411
2803
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.6
8.1
222
1337
PD4HE
NOMESCO Finland
Postoperative lower extremity artery ultrasound examination with Doppler method
4.2
8.1
29
64
J01DC02
ATC
cefuroxime; systemic
1.6
8.1
220
1321
UJD02
NOMESCO Finland
Gastroscopy
1.5
8.0
284
1811
WX726
NOMESCO Finland
High-flow oxygen therapy
6.4
8.0
20
29
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
1.7
8.0
169
948
M10.0
ICD-10 Finland
Idiopathic gout
1.5
8.0
248
1533
RS220
NOMESCO Finland
NA
2.5
8.0
62
236
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
2.9
8.0
47
153
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.8
7.9
135
712
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
2.9
7.9
46
148
M54
ICD-10 Finland
Dorsalgia
1.3
7.9
487
3430
G01AA10
ATC
clindamycin; vaginal
0.7
7.9
176
2475
G72.8
ICD-10 Finland
Other specified myopathies
2.0
7.9
101
480
4910A
ICD-9 Finland
Chronic bronchitis, Simple chronic bronchitis
7.3
7.9
18
23
PEU81
NOMESCO Finland
Thrombectomy or embolectomy of bypass from femoral to popliteal artery
10.0
7.9
15
14
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.3
7.9
628
4592
PD5CD
NOMESCO Finland
Very extensive CT angiography of aorta
2.5
7.9
59
222
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
6.2
7.8
20
30
ZX100
NOMESCO Finland
Oral
2.0
7.8
92
424
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
2.1
7.8
83
368
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.3
7.8
563
4061
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.6
7.8
118
1801
J01CF05
ATC
flucloxacillin; systemic
1.6
7.8
204
1213
M48.0
ICD-10 Finland
Spinal stenosis
1.2
7.8
897
6867
R23.3
ICD-10 Finland
Spontaneous ecchymoses
1.8
7.8
117
594
U04
ICPC
Incontinence urine
1.4
7.8
302
1962
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
1.7
7.8
144
778
E000002
ATC
NA
1.3
7.7
467
3279
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.5
7.7
222
1354
J01FA10
ATC
azithromycin; systemic
1.2
7.7
2555
21546
UJC01
NOMESCO Finland
Scopy of lower throat
2.3
7.7
66
265
E883A
ICD-9 Finland
Fall into hole or other opening in surface
1.5
7.7
259
1633
B37.08
ICD-10 Finland
Other candidal stomatitis
2.7
7.7
49
167
WX111
NOMESCO Finland
Local infiltration anesthesia
0.5
7.7
71
1232
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
2.3
7.7
66
266
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
2.4
7.6
60
231
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.2
7.6
922
7094
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
2.9
7.6
44
141
D01AE16
ATC
amorolfine; topical
0.8
7.6
465
5547
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.4
7.6
298
1939
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
5.0
7.6
23
43
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
0.5
7.6
63
1127
11
HP
Coronary artery bypass surgery
1.6
7.5
194
1151
A02BA03
ATC
famotidine; systemic
1.5
7.5
238
1480
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.7
7.5
286
3652
L04AA13
ATC
leflunomide; oral
1.8
7.5
118
605
PD5AD
NOMESCO Finland
CT of aorta
1.8
7.5
122
635
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
2.1
7.5
80
354
A12BA01
ATC
potassium chloride; oral
1.4
7.5
325
2158
SFA00
NOMESCO Finland
Small filling
0.7
7.5
341
4235
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.4
7.5
419
2909
I95.1
ICD-10 Finland
Orthostatic hypotension
1.5
7.5
264
1685
EBA00
NOMESCO Finland
Extraction of tooth
1.2
7.4
1738
14242
191
Kela drug reimbursment
Erlotinib
4.7
7.4
24
48
A10AE05
ATC
insulin detemir; parenteral
1.4
7.4
314
2075
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.3
7.4
65
266
SPAT1151
SPAT
Treatment of major wounds
2.0
7.4
93
442
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
8.7
7.4
15
16
Z71.6
ICD-10 Finland
Tobacco abuse counselling
8.7
7.4
15
16
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.6
7.4
91
1459
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.4
7.4
287
1866
I21.10
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
2.1
7.4
77
339
WX144
NOMESCO Finland
Subconjunctival anesthesy
2.0
7.4
87
405
Z71.8
ICD-10 Finland
Other specified counselling
1.2
7.4
1151
9095
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.7
7.4
271
3479
K92
ICPC
Atherosclerosis/periph vascular dis
1.9
7.3
105
522
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
0.5
7.3
75
1263
F32
ICD-10 Finland
Depressive episode
1.7
7.3
151
846
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
1.8
7.3
115
593
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
1.9
7.3
95
458
PEE23
NOMESCO Finland
Thrombectomy or embolectomy of femoral artery
3.8
7.3
29
71
PGH44
NOMESCO Finland
Bypass from axillary to bilateral femoral arteries
23.2
7.3
10
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
1.9
7.3
97
473
SPAT1229
SPAT
Assessment of need for aid
1.3
7.3
575
4200
R05CB02
ATC
bromhexine; systemic
2.0
7.3
94
450
RS224
NOMESCO Finland
NA
4.2
7.2
26
58
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.8
7.2
409
4934
H02AB02
ATC
dexamethasone; systemic
1.3
7.2
557
4053
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
0.8
7.2
415
4995
WX890
NOMESCO Finland
Intesive care monitoring
2.4
7.2
58
227
T82.3
ICD-10 Finland
Mechanical complication of other vascular grafts
6.9
7.2
17
23
R85
ICPC
Malignant neopl respiratory other
5.9
7.2
19
30
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
1.7
7.2
153
864
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.5
7.2
227
1414
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.6
7.2
198
1195
G03CA04
ATC
estriol; systemic, vaginal
0.7
7.2
266
3412
4100X
ICD-9 Finland
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
1.7
7.2
130
699
N05AA01
ATC
chlorpromazine; systemic, rectal
2.5
7.2
51
187
RK110
NOMESCO Finland
NA
2.5
7.2
51
187
29500
ICD-8 Finland
Schizophrenia, Simple type
5.5
7.2
20
34
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
7.2
1069
8404
N84.0
ICD-10 Finland
Polyp of corpus uteri
0.6
7.2
110
1675
L85.3
ICD-10 Finland
Xerosis cutis
2.2
7.2
66
276
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.6
7.2
196
1181
I21.4
ICD-10 Finland
Acute subendocardial myocardial infarction
2.0
7.2
81
371
S76
ICPC
Skin infection other
1.4
7.1
298
1965
NFJ52
NOMESCO Finland
Internal fixation of fracture of upper femur with screws and sideplate
2.5
7.1
53
197
R01
ICPC
Pain respiratory system
2.1
7.1
73
320
F31
ICD-10 Finland
Bipolar affective disorder
3.3
7.1
34
97
A41.8
ICD-10 Finland
Other specified sepsis
1.8
7.1
113
585
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.7
7.1
126
676
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.4
7.1
329
2211
I70.8
ICD-10 Finland
Atherosclerosis of other arteries
2.9
7.1
41
132
I47.2
ICD-10 Finland
Ventricular tachycardia
1.7
7.1
150
848
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
5.7
7.1
19
31
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
0.7
7.1
154
2173
2918A
ICD-9 Finland
Alcoholic psychoses, Other specified alcoholic psychosis
4.4
7.1
24
51
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.2
7.0
1889
15645
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
3.5
7.0
31
83
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
2.5
7.0
53
200
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
0.7
7.0
328
4060
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
3.4
7.0
32
88
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
3.2
7.0
34
98
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.5
7.0
202
1230
N06AA04
ATC
clomipramine; systemic
2.1
7.0
77
347
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
2.4
7.0
57
225
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
2.5
7.0
50
184
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.6
7.0
194
1173
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.3
7.0
428
3013
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
2.5
7.0
50
185
F05.8
ICD-10 Finland
Other delirium
2.5
7.0
50
185
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
3.1
6.9
35
104
I70.0
ICD-10 Finland
Atherosclerosis of aorta
2.7
6.9
45
156
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
6.0
6.9
18
28
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
6.0
6.9
18
28
N87
ICPC
Parkinsonism
0.4
6.9
29
652
JN4CD
NOMESCO Finland
Very extensive body CT
1.4
6.9
274
1787
X58
ICD-10 Finland
Exposure to other specified factors
1.3
6.9
582
4287
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
1.9
6.9
98
489
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.2
6.9
815
6254
8000/3-C34.3
ICD-O-3
Neoplasm, malignant of lower lobe, lung
8.7
6.9
14
15
D06BX01
ATC
metronidazole; topical
0.7
6.9
269
3422
B37.0
ICD-10 Finland
Candidal stomatitis
2.3
6.9
59
240
S91.0
ICD-10 Finland
Open wound of ankle
2.4
6.9
56
222
J38.4
ICD-10 Finland
Oedema of larynx
3.3
6.9
32
90
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
6.8
156
899
ZYC01
SPAT
NA
0.6
6.8
90
1416
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
1.8
6.8
101
512
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
5.8
6.8
18
29
SAA03
NOMESCO Finland
Extended examination of mouth
0.9
6.8
1410
14868
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.3
6.8
404
2835
UKC02
NOMESCO Finland
Cystoscopy
1.2
6.8
1318
10625
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
2.6
6.8
45
160
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
1.7
6.8
121
652
49101
ICD-8 Finland
Chronic bronchitis, Nonpurulenta (simplex)
4.6
6.7
22
45
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
4.0
6.7
25
58
B80
ICPC
Iron deficiency anaemia
1.8
6.7
108
563
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.4
6.7
310
2086
30188
ICD-8 Finland
Personality disorders, Alia definita
3.5
6.7
29
77
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
2.6
6.7
45
161
53298
ICD-8 Finland
Ulcer of duodenum, Aliud definitum, perforatione non indicata
3.1
6.7
34
102
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
4.1
6.7
24
54
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
3.2
6.7
33
97
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
2.4
6.7
51
195
79301
ICD-8 Finland
Observation, without need for further medical care, Observatio post tentationem suicidii
6.1
6.7
17
26
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.0
6.7
83
394
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.7
6.7
161
2221
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.8
6.6
111
586
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.8
6.6
103
529
ZPB96
NOMESCO Finland
Other material in vessel transplant
3.9
6.6
25
59
A11CC03
ATC
alfacalcidol; systemic
1.7
6.6
137
769
N03AX09
ATC
lamotrigine; oral
1.8
6.6
103
530
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.8
6.6
912
9959
I45.9
ICD-10 Finland
Conduction disorder, unspecified
2.1
6.6
70
313
F51.0
ICD-10 Finland
Nonorganic insomnia
1.3
6.6
449
3209
R74
ICPC
Upper respiratory infection acute
1.2
6.6
890
6923
L17
ICPC
Foot/toe symptom/complaint
1.2
6.6
1566
12831
R31
ICD-10 Finland
Unspecified haematuria
1.2
6.6
788
6052
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
1.7
6.6
135
756
C07AB02
ATC
metoprolol; systemic
1.2
6.6
1562
12803
E9609
ICD-8 Finland
Fight, brawl, rape
2.9
6.6
38
123
N04BD01
ATC
selegiline; oral
0.4
6.5
25
583
N03AX12
ATC
gabapentin; oral
1.2
6.5
836
6467
S83.2
ICD-10 Finland
Tear of meniscus, current
0.6
6.5
129
1852
K99
ICPC
Cardiovascular disease other
1.5
6.5
207
1293
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.8
6.5
98
497
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.5
6.5
214
1345
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
6.5
558
4123
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
2.4
6.5
50
193
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
2.5
6.5
46
169
GAC00
NOMESCO Finland
Biopsy of pleura
2.8
6.5
38
125
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
1.6
6.5
174
1045
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
1.6
6.4
160
945
SPAT1252
SPAT
Overall medication plan or its review
1.3
6.4
490
3562
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.3
6.4
424
3019
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
0.7
6.4
227
2928
PFH63
NOMESCO Finland
Bypass from femoral or popliteal artery to distal posterior tibial artery
4.1
6.4
23
52
TK800
NOMESCO Finland
Hemodialysis
1.7
6.4
125
692
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
1.5
6.4
223
1419
A07AA09
ATC
vancomycin; oral
2.0
6.4
77
362
R4190
NOMESCO Finland
Nutritional therapy
1.7
6.4
133
748
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.4
6.4
274
1820
N05AX12
ATC
aripiprazole; systemic
2.3
6.4
57
234
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
3.0
6.4
33
101
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.1
6.4
68
306
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.8
6.3
106
557
R03DA05
ATC
aminophylline; systemic, rectal
2.5
6.3
46
172
64199
ICD-8 Finland
Abortion induced for other legal indications, Without mention of sepsis or toxaemia
1.5
6.3
209
1316
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
3.2
6.3
31
91
A02BX05
ATC
bismuth subcitrate; oral
1.8
6.3
106
559
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
2.1
6.3
63
275
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.2
6.3
30
86
K03.0
ICD-10 Finland
Excessive attrition of teeth
0.5
6.3
41
790
A04AA55
ATC
palonosetron, combinations; systemic
1.8
6.3
95
485
KCD02
NOMESCO Finland
Transurethral resection of bladder
1.5
6.3
185
1136
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.6
6.3
163
969
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.6
6.3
157
928
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.0
6.3
70
320
PG9AC
NOMESCO Finland
Arteriography with X-ray not elsewhere classified
2.6
6.3
42
150
61208
ICD-8 Finland
Acute salpingitis and oophoritis, Alia definita
3.6
6.3
26
67
PJA12
NOMESCO Finland
Sentinel node biopsy
0.7
6.3
174
2339
SFA40
NOMESCO Finland
Replacement of krone of tooth
0.8
6.3
812
8922
A69
ICPC
General and Unspecified, Other reason for encounter NEC
1.6
6.3
145
841
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.4
6.2
251
1645
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.1
6.2
31
92
N02BB73
ATC
aminophenazone, combinations with psycholeptics; systemic
3.1
6.2
31
92
SPAT1301
SPAT
No procedures
1.1
6.2
2176
18343
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.0
6.2
76
360
PC1AC
NOMESCO Finland
Angiography of aorta and abdominal arteries
3.2
6.2
30
87
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.4
6.2
331
2281
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
9.3
6.2
12
12
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
6.2
203
1276
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
1.6
6.2
138
792
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
8.1
6.2
13
15
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
5.5
6.2
17
29
XCK10
NOMESCO Finland
Photography of fundus of eye
1.2
6.2
694
5296
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
6.2
220
1407
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
6.2
609
4579
2910A
ICD-9 Finland
Alcoholic psychoses, Alcohol withdrawal delirium
4.8
6.2
19
37
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
1.7
6.2
108
577
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
6.2
500
3667
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
6.2
605
4544
M01AB51
ATC
indometacin, combinations; oral, rectal
1.6
6.1
134
764
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
2.1
6.1
61
265
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.4
6.1
311
2125
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.3
6.1
492
3602
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
3.0
6.1
33
104
R50
ICPC
Respiratory, Medication/prescr/renewal
3.6
6.1
25
64
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
0.8
6.1
407
4801
L02.0
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of face
2.1
6.1
61
267
PG1ST
NOMESCO Finland
Endovascular arterial thrombolysis with radiological guidance not elsewhere classified
4.2
6.1
21
46
S02
ICPC
Pruritus
1.5
6.1
173
1057
GAA31
NOMESCO Finland
Thoracoscopy
3.3
6.1
28
79
44020
ICD-8 Finland
Arteriosclerosis, Of arteries of the extremities
5.7
6.1
16
26
29560
ICD-8 Finland
Residual schizophrenia
5.7
6.1
16
26
XF404
NOMESCO Finland
Ambulatory ECG
1.2
6.1
638
4833
PEG23
NOMESCO Finland
Operation for aneurysm of femoral artery
6.9
6.0
14
19
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
0.6
6.0
84
1304
R07.3
ICD-10 Finland
Other chest pain
1.3
6.0
521
3851
T82.8
ICD-10 Finland
Other specified complications of cardiac and vascular prosthetic devices, implants and grafts
4.7
6.0
19
38
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
2.4
6.0
47
183
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
4.9
6.0
18
34
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
16.7
6.0
9
5
K29.8
ICD-10 Finland
Duodenitis
2.2
6.0
58
250
R03CC03
ATC
terbutaline; systemic
2.5
6.0
43
159
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4010399)
1724
4820
3.11
307.65
1.6
1.4
—
—
—
0
0
(3000492) Spirometry study
1627
4207
3.35
307.65
1.8
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
6947
69971
0.49
300.06
5.2
5.6
mmol/l
2.2
2.4
61.53
6084
61909
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
6651
67694
0.50
288.38
4.6
4.9
mmol/l
4.0
4.3
51.90
5837
60129
(3027801) Oxygen [Partial pressure] in Arterial blood
2779
10768
2.33
286.63
6.6
6.0
kpa
9.6
12.0
180.21
2597
10189
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2780
10778
2.33
286.32
6.6
6.0
kpa
5.3
5.0
47.71
2609
10204
(3003396) Base excess in Arterial blood by calculation
2776
10775
2.32
284.99
6.6
6.0
mmol/l
2.0
0.9
32.27
2239
8206
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6563
66901
0.50
280.65
4.6
4.9
mmol/l
1.3
1.4
27.71
5690
58859
(3007461) Platelets [#/volume] in Blood
8045
76560
0.48
273.89
43.4
27.2
e9/l
248.7
231.2
80.89
7741
73835
(3010813) Leukocytes [#/volume] in Blood
8049
76582
0.48
273.73
43.5
27.3
e9/l
8.2
7.0
122.68
7709
73500
(3026361) Erythrocytes [#/volume] in Blood
8047
76566
0.48
273.56
43.4
27.2
e12/l
4.3
4.3
37.10
7702
73442
(3024731) MCV [Entitic volume]
8047
76566
0.48
273.56
43.3
27.1
fl
92.6
92.0
17.17
7815
74829
(3000963) Hemoglobin [Mass/volume] in Blood
8048
76572
0.48
273.54
43.8
27.4
g/l
127.9
131.7
75.20
7818
74834
(3035941) MCH [Entitic mass]
8047
76563
0.48
273.41
43.2
27.1
pg
30.3
30.5
12.01
7815
74824
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7024
69800
0.50
270.29
5.3
5.4
mmol/l
6.2
6.2
2.59
6084
60985
(3020564) Creatinine [Moles/volume] in Serum or Plasma
7793
74852
0.49
269.12
35.6
22.2
umol/l
94.9
89.1
16.86
7786
74809
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1539
4672
2.82
260.90
6.6
7.8
mmol/l
25.1
24.0
22.15
1402
4285
(3019060) Gas panel - Arterial blood
1876
6315
2.58
260.11
4.5
4.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
8022
76126
0.49
260.00
37.5
22.4
mmol/l
4.0
4.0
15.62
7762
73823
(3019550) Sodium [Moles/volume] in Serum or Plasma
8021
76061
0.50
257.24
37.4
22.2
mmol/l
139.0
139.6
55.60
7769
73873
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7805
74580
0.50
253.16
13.8
11.5
u/l
23.8
24.0
0.24
7479
70696
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6411
64681
0.53
236.47
4.2
4.4
mmol/l
1.3
1.2
10.77
5504
56244
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6854
67450
0.54
224.09
7.4
7.1
mmol/mol
42.8
41.4
19.43
6063
60264
(3009343) pH of Capillary blood
1685
5772
2.50
222.97
5.3
3.4
ph
7.4
7.4
0.01
205
772
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1693
5854
2.48
219.40
5.3
3.3
kpa
5.4
5.1
31.44
1580
5310
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1629
5576
2.49
215.43
5.2
3.3
mmol/l
2.7
1.7
19.60
1320
3951
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
570
1050
4.42
204.43
1.2
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
7621
72071
0.55
200.56
29.3
18.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
2337
9848
2.07
186.32
6.8
6.3
%
93.0
95.6
56.99
2237
9448
(3022313) Gas panel - Capillary blood
1250
4084
2.56
180.42
5.4
3.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3335
16045
1.87
180.31
2.3
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
6910
66340
0.58
173.42
29.6
17.9
ml/min/173m2
67.8
68.8
3.24
5969
55059
(3023368) Bacteria identified in Blood by Culture
4938
27379
1.70
160.04
5.5
4.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1047
3357
2.59
156.13
2.9
2.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
725
1962
3.02
148.07
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
725
1963
3.02
147.93
1.6
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
468
982
3.85
141.21
2.5
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6825
64559
0.61
139.40
5.0
4.7
mu/l
2.0
2.1
2.24
6000
56628
(3028626) Oxygen [Partial pressure] in Capillary blood
738
2101
2.87
137.67
3.9
2.5
kpa
7.3
7.8
15.72
685
1936
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2362
10995
1.85
136.09
2.3
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2366
11041
1.85
135.13
2.2
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
804
2423
2.72
134.86
4.3
2.7
mmol/l
25.9
24.4
12.18
704
2110
(3042631) Mycobacterium sp identified in Specimen
517
1320
3.17
116.02
2.8
2.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
7961
71765
0.63
115.47
32.9
18.1
mg/l
31.7
29.3
8.65
7464
59681
(3021901) Oxygen saturation in Capillary blood
627
1821
2.80
112.37
3.7
2.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
670
2092
2.60
104.33
1.5
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
948
3531
2.20
99.82
6.1
3.8
mmol/l
25.5
24.7
11.09
892
3147
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
378
881
3.44
97.82
3.7
3.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
5684
54261
0.67
97.73
41.0
25.1
g/l
327.2
331.2
160.87
5540
53614
(3024891) Influenza virus A+B Ag [Presence] in Specimen
506
1454
2.81
92.28
1.4
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
641
2107
2.47
89.55
5.0
3.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1205
5116
1.94
88.98
7.0
5.8
mmol/l
25.7
24.5
17.09
1187
5059
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1850
9018
1.72
87.11
7.8
6.6
g/l
122.5
119.3
8.55
1798
8681
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
457
1284
2.86
86.80
1.9
1.8
ug/l
20.1
26.0
1.92
449
1243
(3014111) Lactate [Moles/volume] in Serum or Plasma
1716
8232
1.74
85.40
6.7
5.6
mmol/l
1.4
1.4
0.45
1620
7873
(3005322) IgE [Units/volume] in Serum or Plasma
734
2620
2.28
85.24
1.4
1.3
u/ml
297.0
276.7
0.25
691
2355
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
242
453
4.26
84.75
3.5
3.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1484
18656
0.57
84.12
1.6
1.6
mmol/l
1.4
1.3
8.79
1227
15065
(3044889) 12 lead EKG panel
5644
53131
0.69
81.70
5.3
4.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
1616
7751
1.73
80.06
7.6
6.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
4238
41916
0.68
79.52
5.0
5.9
ug/l
3.5
4.9
2.34
3604
36716
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1006
4240
1.94
75.37
4.0
3.8
mmol/l
24.8
23.9
10.85
928
3757
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
3247
33528
0.67
74.94
4.5
5.1
%
21.3
22.5
4.78
1652
18953
(3002032) Base excess in Venous blood by calculation
1793
9122
1.64
70.48
4.4
3.6
mmol/l
2.8
1.7
21.04
1463
7293
(3002385) Erythrocyte distribution width [Ratio]
6022
55412
0.71
70.42
37.5
22.6
%
14.8
14.0
216.49
5853
54011
(3009542) Hematocrit [Volume Fraction] of Blood
6543
59350
0.71
69.94
32.9
20.3
%
37.1
37.5
1.52
3594
33181
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5565
51778
0.71
68.58
4.0
3.7
pmol/l
15.5
15.2
11.22
4871
45053
(3018851) Theophylline [Moles/volume] in Serum or Plasma
71
39
14.37
67.85
1.4
1.8
umol/l
51.7
53.6
0.09
71
39
(3012544) pH of Venous blood
1834
9467
1.61
67.75
4.4
3.6
ph
7.4
7.4
—
7
49
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1784
9160
1.62
67.31
4.4
3.6
kpa
6.2
5.8
46.59
1704
8867
(42870588) Differential panel, method unspecified - Blood
4232
26307
1.40
61.78
5.6
5.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
5206
33565
1.38
60.79
6.1
5.6
%
0.6
0.6
13.68
4907
30680
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2175
23522
0.67
59.92
3.0
3.5
ug/l
0.8
0.9
1.54
1540
17712
(4015189)
137
214
5.07
59.41
2.1
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1196
5726
1.71
58.51
1.8
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2445
13873
1.48
57.83
2.9
2.8
mmol/l
0.8
0.8
11.87
2214
12755
(3013290) Carbon dioxide [Partial pressure] in Blood
558
2107
2.13
56.12
6.7
3.8
kpa
5.2
4.9
11.30
542
2048
(3012501) Base excess in Blood by calculation
557
2106
2.13
55.83
6.7
3.8
mmol/l
3.3
2.5
6.37
434
1376
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
4880
31422
1.37
55.83
4.3
3.1
ng/l
2635.7
2008.9
9.80
4335
27431
(3006184) Hemoglobin [Mass/volume] in Capillary blood
574
2198
2.10
55.68
2.7
2.2
g/l
125.0
126.3
0.52
403
1623
(3006504) Eosinophils/100 leukocytes in Blood
5289
34498
1.36
55.68
6.2
5.6
%
2.6
2.9
15.84
4974
31492
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1267
6239
1.66
55.66
8.5
6.2
mmol/l
25.5
24.3
20.25
1213
5795
(3027315) Oxygen [Partial pressure] in Blood
559
2120
2.12
55.60
6.7
3.8
kpa
7.9
8.4
10.03
543
2060
(3019069) Monocytes/100 leukocytes in Blood
5307
34692
1.36
54.75
6.5
5.9
%
9.0
9.1
1.69
5003
31733
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1263
6272
1.65
53.59
2.2
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
526
1981
2.13
53.23
1.5
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
5698
37763
1.35
53.11
6.1
5.4
e9/l
0.2
0.2
1.14
4954
32128
(3010421) pH of Blood
601
2415
2.00
51.16
6.6
3.7
ph
7.4
7.4
0.85
543
2049
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2594
15192
1.43
51.07
1.9
1.6
mg/l
1.5
1.7
1.34
2128
11913
(3002030) Lymphocytes/100 leukocytes in Blood
5343
35203
1.34
51.01
6.4
5.8
%
21.0
25.3
140.99
5011
31964
(40767503) Oxygen content in Capillary blood by calculation
528
2034
2.09
50.38
3.6
2.4
%
15.2
15.8
2.95
314
1082
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
498
1900
2.10
48.72
1.5
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
459
1712
2.15
47.58
1.4
1.5
g/l
31.7
31.2
0.37
399
1537
(1761868) Lipid panel - Serum or Plasma
1474
16597
0.66
47.58
4.0
3.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
5231
34607
1.33
47.23
6.2
5.5
%
63.4
59.2
108.08
4913
31605
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1710
9365
1.50
47.07
3.9
3.1
ng/l
339.0
270.3
3.77
1607
8597
(3001604) Monocytes [#/volume] in Blood
5464
36501
1.32
45.41
5.8
5.2
e9/l
0.7
0.6
70.30
4687
30619
(3020779) Urea [Moles/volume] in Serum or Plasma
1625
8876
1.50
45.15
6.1
6.2
mmol/l
12.6
11.9
2.78
1493
8296
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1021
5010
1.66
45.03
9.7
8.2
—
—
—
0
0
(3019977) pH of Arterial blood
206
537
3.05
44.65
2.4
2.1
ph
7.4
7.4
0.17
92
184
(3006315) Basophils [#/volume] in Blood
5491
36774
1.31
44.45
5.8
5.2
e9/l
0.0
0.0
9.08
4733
30889
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1169
5993
1.59
43.10
8.5
7.4
%
0.6
0.7
6.50
1157
5946
(3023199) Leukocytes [#/volume] in Pleural fluid
406
1501
2.16
43.03
1.5
1.5
e6/l
2159.9
1884.1
0.28
304
1085
(3012441) Differential panel - Pleural fluid
364
1293
2.25
42.52
1.5
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1168
6012
1.58
42.30
8.5
7.2
%
1.6
1.3
20.48
1158
5964
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1278
6722
1.55
42.10
1.7
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
2081
12119
1.42
41.10
2.1
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
362
1302
2.22
41.05
1.5
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
717
3274
1.76
41.02
2.6
2.1
ug/l
539.6
648.5
0.37
671
3109
(3028308) Erythrocytes [#/volume] in Pleural fluid
374
1372
2.18
40.42
1.5
1.5
e6/l
49349.1
69612.5
0.89
238
812
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
393
1475
2.13
40.10
1.5
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2064
12059
1.41
39.90
5.2
5.3
mmol/l
1.1
1.0
3.44
1849
11022
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
381
1423
2.14
39.37
1.4
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1400
7618
1.50
39.23
4.0
3.0
kpa
4.3
4.4
1.02
1322
7328
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
326
1146
2.27
39.05
1.4
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
5514
37353
1.29
38.98
6.0
5.3
e9/l
1.7
1.9
8.17
4804
31875
(3014007) Fractional oxyhemoglobin in Arterial blood
1142
5976
1.55
38.32
8.8
7.4
%
91.6
94.0
29.00
1135
5952
(3017569) Oxygen content in Arterial blood
174
455
3.03
37.58
2.2
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
351
1299
2.15
37.12
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
785
3780
1.67
37.02
2.5
2.6
u/ml
0.3
0.4
0.70
457
2163
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
318
1140
2.22
36.38
1.3
1.3
u/l
560.7
377.6
0.83
300
1075
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
883
4409
1.62
36.10
2.0
1.9
ug/l
1.6
2.3
1.65
759
3781
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
317
1181
2.14
33.00
1.5
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
822
4131
1.60
32.65
2.3
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
2016
12094
1.37
32.57
7.7
6.0
mmol/l
103.5
104.6
15.81
1945
11804
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3019
28725
0.77
32.25
5.1
4.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
313
1177
2.12
31.83
1.4
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
297
1095
2.16
31.75
1.4
1.4
mmol/l
6.4
6.3
0.07
272
1013
(3012516) Albumin [Mass/volume] in Urine
2872
27436
0.77
31.42
3.2
3.3
mg/l
260.4
371.2
1.16
1996
17755
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
92
177
4.10
31.33
4.1
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
306
1150
2.12
31.17
1.5
1.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
261
928
2.23
30.51
1.3
1.3
u/l
13.8
13.8
0.01
241
848
(3028271) Lactate [Moles/volume] in Capillary blood
368
1503
1.95
29.89
2.5
1.8
mmol/l
1.7
1.7
0.14
360
1466
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
120
290
3.27
29.57
1.3
1.3
u/ml
2.3
1.3
0.51
86
149
(3019150) Specific gravity of Urine by Refractometry
1694
17277
0.73
29.06
5.0
4.7
kg/l
1.0
1.0
0.36
307
2807
(3020682) Albumin/Creatinine [Ratio] in Urine
3100
29105
0.78
28.90
4.0
4.0
mg/mmol
19.1
9.8
9.80
2062
18562
(3024928) Oxygen saturation in Venous blood
424
1836
1.84
28.86
2.5
2.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
289
4373
0.51
28.48
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1025
11339
0.68
28.44
13.3
8.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
3207
29926
0.78
28.23
2.3
2.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2908
27436
0.78
27.97
3.1
3.2
mmol/l
6.8
7.2
5.36
2315
22182
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
263
974
2.14
27.85
1.5
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1616
9592
1.37
27.47
2.1
1.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
300
1175
2.03
27.44
2.4
1.8
%
86.9
89.1
5.16
294
1161
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
747
3825
1.57
27.32
2.1
1.8
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
236
848
2.21
26.94
1.4
1.4
u/l
13.2
13.6
0.51
225
808
(3009261) Glucose [Presence] in Urine by Test strip
4237
38168
0.80
26.90
4.6
4.2
estimate
0.0
0.0
0.80
895
6929
(3047181) Lactate [Moles/volume] in Blood
587
2848
1.65
26.80
7.6
5.4
mmol/l
1.4
1.3
0.19
538
2506
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1061
5878
1.46
26.67
2.5
2.2
nmol/l
362.6
383.0
2.17
964
5303
(3013707) Erythrocyte sedimentation rate by Westergren method
6382
55015
0.81
26.26
5.0
4.2
mm/h
20.0
15.1
72.29
5886
49503
(3021601) Nitrite [Presence] in Urine by Test strip
4179
37630
0.81
26.16
6.1
5.5
estimate
0.0
0.0
0.00
917
7113
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
166
517
2.54
26.05
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
539
2592
1.66
25.47
3.3
3.1
nmol/l
0.9
0.8
2.77
427
1983
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
217
772
2.23
25.40
1.5
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2111
13233
1.31
24.53
2.9
2.6
%
18.5
21.6
19.81
1757
11007
(3035350) Ketones [Presence] in Urine by Test strip
4206
37679
0.81
24.47
4.5
4.1
estimate
0.0
0.0
0.00
911
7092
(3037467) Urinalysis macro (dipstick) panel - Urine
6352
54577
0.82
24.15
5.5
4.8
—
—
—
0
0
(3035880) pH of Pleural fluid
195
678
2.28
24.12
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1891
11715
1.32
23.88
2.9
3.9
u/l
238.5
251.0
4.19
1758
10939
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2213
14014
1.29
23.73
2.8
2.5
g/l
2.2
2.2
0.18
2017
12773
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
779
4184
1.49
22.82
1.7
1.5
%
1.9
1.7
4.99
612
3295
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
198
719
2.18
22.11
1.0
1.1
g/l
1.6
1.6
0.24
175
637
(3009445) Proteinase 3 Ab [Units/volume] in Serum
680
3573
1.52
22.11
1.3
1.5
u/ml
18.2
18.3
0.01
15
89
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
7149
60490
0.83
21.89
9.2
7.6
u/l
85.1
82.4
2.87
6786
56251
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
53
90
4.64
21.13
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1810
17595
0.77
20.93
1.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
2322
15084
1.26
19.79
2.8
2.6
umol/l
10.1
11.9
32.79
2111
13732
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1277
7680
1.34
19.54
2.0
2.1
g/l
0.2
0.2
3.34
1143
7043
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
189
712
2.10
19.30
1.2
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
187
702
2.11
19.27
1.5
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
187
702
2.11
19.27
1.5
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
187
702
2.11
19.27
1.5
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2713
17999
1.24
19.04
5.9
4.1
ng/l
401.8
509.6
0.38
2493
15985
(3029937) Albumin [Presence] in Urine by Test strip
2290
21452
0.80
19.02
5.0
4.6
estimate
0.0
0.0
0.50
826
6594
(3013650) Neutrophils [#/volume] in Blood by Automated count
5987
42913
1.19
18.38
8.8
8.3
e9/l
5.3
4.4
103.16
5235
36845
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
517
2677
1.54
17.99
1.5
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
369
1775
1.65
17.49
1.8
2.0
umol/l
30.9
32.6
0.79
308
1412
(3003181) Sodium [Moles/volume] in Urine
350
1669
1.67
17.16
1.4
1.3
mmol/l
59.8
62.6
0.68
283
1345
(44806118)
200
807
1.96
17.00
1.4
1.3
—
—
—
0
0
(44790049)
200
808
1.96
16.95
1.4
1.3
—
—
—
0
0
(44790048)
200
808
1.96
16.95
1.4
1.3
—
—
—
0
0
(44790047)
200
808
1.96
16.95
1.4
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
648
3563
1.45
16.84
4.8
3.7
mmol/l
1.4
1.4
1.45
632
3491
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
452
2309
1.56
16.73
1.3
1.4
iu/ml
17.2
17.3
—
8
56
(3027945) Reticulocytes/100 erythrocytes in Blood
1942
12594
1.25
16.47
2.2
2.3
%
1.9
1.7
15.92
1646
10908
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1043
10600
0.75
16.45
4.6
5.1
%
34.1
33.7
0.48
691
6753
(3011397) Hemoglobin [Presence] in Urine by Test strip
1986
18641
0.80
16.38
4.0
4.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
66
1426
0.36
16.37
1.7
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
493
5669
0.67
16.34
1.9
2.0
nmol/l
10.4
10.7
0.23
374
4732
(3023383) Lactate [Moles/volume] in Pleural fluid
116
384
2.39
16.19
1.3
1.3
mmol/l
3.5
3.5
0.10
104
344
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
145
530
2.16
16.07
1.4
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
519
2759
1.50
15.99
1.5
1.6
titre
106.4
274.0
3.29
25
139
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
893
5244
1.36
15.88
1.5
1.6
g/l
1.7
1.5
5.92
762
4412
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
144
529
2.15
15.77
1.4
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
555
3005
1.47
15.62
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
1089
10923
0.76
15.55
1.4
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
285
1337
1.69
14.92
2.9
3.2
e9/l
5.3
4.4
6.53
285
1332
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
115
394
2.30
14.90
2.3
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
162
638
2.01
14.81
1.4
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
50
108
3.65
14.76
1.5
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1372
8648
1.28
14.68
2.4
2.6
umol/l
8.7
10.7
2.20
1152
7551
(3013512) EKG study
2993
26743
0.84
14.47
6.0
4.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
49
1148
0.33
14.45
1.4
1.5
mg/l
10.2
3.1
0.93
41
856
(3020891) Body temperature
683
3900
1.40
14.40
6.1
4.4
—
—
—
0
0
(3026782) Osmolality of Urine
2751
18735
1.20
14.15
3.2
3.0
mosm/kgh2o
533.5
561.2
10.96
2357
15893
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
732
4243
1.38
14.11
6.5
4.5
%
1.9
1.5
11.91
692
3985
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
887
0.25
14.05
1.5
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
134
502
2.11
14.02
1.8
1.7
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
109
379
2.27
13.69
1.3
1.3
ug/l
53.7
355.8
1.73
73
188
(3040151) Glucose [Moles/volume] in Capillary blood
256
1196
1.70
13.64
9.7
7.8
mmol/l
7.5
7.4
0.08
219
961
(40761535) Cells panel - Urine sediment
781
8018
0.75
13.09
3.9
3.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
6510
54520
0.87
13.05
6.1
5.2
e6/l
1582.1
1602.6
0.01
167
985
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
39
77
3.99
13.04
1.1
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1121
6989
1.29
13.04
2.6
2.3
u/l
33.6
50.0
0.91
934
5923
(3035637) Corticotropin [Mass/volume] in Plasma
179
763
1.85
13.04
1.5
1.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
717
4198
1.36
12.99
6.6
4.5
%
0.9
0.9
0.30
674
3941
(3008757) Leukocyte morphology finding [Identifier] in Blood
224
1024
1.73
12.94
3.2
3.9
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
399
2112
1.50
12.62
8.2
6.0
mmol/l
103.5
105.1
7.56
365
1889
(3039000) Anion gap in Blood
399
2112
1.50
12.62
8.2
6.0
mmol/l
11.0
11.4
1.43
365
1889
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
174
743
1.85
12.62
1.5
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
4503
38657
0.86
12.58
2.3
2.2
pmol/l
88.4
92.1
6.05
2536
20497
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
113
415
2.15
12.49
1.5
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
113
415
2.15
12.49
1.5
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
113
415
2.15
12.49
1.5
1.7
—
—
—
0
0
(3015736) pH of Urine
3410
29843
0.86
12.25
4.1
3.9
—
5.8
—
0
26
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
112
414
2.13
12.19
1.5
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2887
20019
1.17
11.68
5.1
4.0
%
80.2
80.5
0.21
2806
19572
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
87
295
2.33
11.65
1.4
1.4
%
17.6
20.2
0.43
73
240
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
177
785
1.78
11.40
1.5
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
332
1741
1.51
11.03
1.2
1.2
titre
154.0
172.4
—
10
34
(3043409) Potassium [Moles/volume] in Arterial blood
531
3048
1.38
10.91
5.3
3.9
mmol/l
4.0
3.9
2.03
474
2840
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
86
299
2.27
10.90
2.7
2.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
86
299
2.27
10.90
2.7
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1064
6737
1.26
10.88
3.4
3.7
%
1.0
0.9
0.50
382
2093
(3014891) Appearance of Pleural fluid
62
185
2.64
10.86
1.5
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
962
6034
1.27
10.64
3.2
3.7
%
0.7
0.6
0.13
265
1470
(3004451) EKG impression Narrative
125
508
1.94
10.60
1.4
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3061
21457
1.16
10.60
3.3
3.1
u/l
36.5
36.9
0.06
2860
20036
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
579
6014
0.74
10.50
1.6
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
32
784
0.32
10.46
1.3
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
176
801
1.74
10.42
1.3
1.3
mosm/kgh2o
273.8
276.4
0.65
130
583
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
144
618
1.84
10.37
1.7
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
233
2841
0.64
10.32
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3459
24523
1.15
10.17
2.6
2.3
mg/l
3.5
3.1
14.71
2882
20537
(3013139) Helicobacter pylori Ag [Presence] in Stool
397
4352
0.71
10.14
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
1006
6383
1.26
10.10
3.4
3.8
%
0.1
0.1
0.10
358
1934
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5806
42640
1.13
9.90
6.3
6.0
umol/l
11.7
12.9
7.62
5486
40272
(3020630) Protein [Mass/volume] in Serum or Plasma
1343
8821
1.22
9.80
2.0
2.6
g/l
64.9
65.9
4.81
1174
7830
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
311
3530
0.68
9.68
1.3
1.3
au/ml
30.9
59.8
—
8
145
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2109
14449
1.18
9.66
2.1
1.9
s
30.9
30.3
4.62
2044
13986
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
321
1720
1.48
9.66
1.3
1.4
g/l
0.2
0.2
0.43
305
1612
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2271
20205
0.86
9.64
1.8
1.8
pmol/l
20430532.8
22695861.6
0.08
1767
15990
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
311
1658
1.49
9.60
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
899
5672
1.26
9.47
1.5
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
87
324
2.12
9.40
1.6
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
87
324
2.12
9.40
1.6
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
5217
38145
1.13
9.35
5.1
4.6
g/l
32.2
34.2
105.43
4755
34903
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
322
1743
1.46
9.23
1.6
1.6
iu/ml
12.3
9.8
0.10
89
455
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
87
327
2.10
9.19
1.6
1.8
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
69
236
2.30
9.16
2.2
1.8
mmol/l
0.9
0.6
0.20
63
217
(3052851) Hemolysis interference index of Serum or Plasma
473
2746
1.37
9.12
4.5
3.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
106
430
1.94
9.11
1.8
2.1
mmol/l
8.1
9.3
2.65
89
326
(3022217) INR in Platelet poor plasma by Coagulation assay
2181
15051
1.17
9.08
31.7
32.5
inr
1.6
1.6
0.03
275
1980
(4034850)
205
2489
0.64
8.95
20.5
12.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
5343
39200
1.13
8.88
13.9
11.9
inr
1.4
1.4
1.21
1425
10475
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
111
462
1.89
8.86
1.4
1.4
%
67.4
65.7
0.19
89
367
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
324
1780
1.44
8.62
1.4
1.4
g/l
1.1
1.1
0.52
308
1671
(4133840)
34
84
3.18
8.36
1.4
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5474
40344
1.12
8.15
7.7
5.8
mmol/l
1.2
1.2
18.49
4972
35850
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1414
9493
1.19
8.14
5.1
3.8
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
68
244
2.19
8.12
1.4
1.4
umol/l
59.7
79.6
1.08
45
128
(3027273) Bicarbonate [Moles/volume] in Venous blood
811
5154
1.25
8.05
4.9
3.3
mmol/l
25.8
24.9
8.70
781
5004
(4062490)
119
524
1.79
8.00
1.1
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
912
5907
1.23
7.62
3.5
3.8
%
0.3
0.4
0.02
298
1618
(3001893) Eosinophils/100 leukocytes in Pleural fluid
97
409
1.87
7.51
1.3
1.4
%
3.1
2.8
0.13
81
332
(3020191) Ethanol [Moles/volume] in Serum or Plasma
95
399
1.88
7.45
1.5
1.2
promille
1.2
1.0
0.86
74
303
(3016038) Potassium [Moles/volume] in Urine
129
595
1.71
7.43
1.1
1.1
mmol/l
33.5
35.5
0.52
106
486
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
157
764
1.62
7.38
1.3
1.3
nmol/l
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3525
25452
1.12
7.29
2.9
2.5
u/l
55.8
60.1
4.99
3236
23269
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
233
1246
1.48
7.20
6.7
5.9
mg/l
12.8
12.4
0.88
206
1128
(3028192) IgG subclass 2 [Mass/volume] in Serum
116
525
1.74
7.16
1.1
1.4
g/l
2.7
3.0
0.95
86
369
(3000494) Fungus identified in Specimen by Culture
1238
8316
1.19
7.07
1.6
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1319
11967
0.85
6.96
1.2
1.2
u/ml
1.7
1.7
0.01
245
2815
(3000850) Epithelial cells [#/volume] in Urine
2786
19886
1.13
6.92
3.0
2.8
e6/l
5.0
4.1
4.67
2463
17407
(3027135) IgG subclass 1 [Mass/volume] in Serum
115
525
1.73
6.90
1.1
1.4
g/l
7.5
7.2
0.30
85
366
(3024139) IgG subclass 3 [Mass/volume] in Serum
115
525
1.73
6.90
1.1
1.4
g/l
0.6
0.4
2.15
86
370
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
45
145
2.44
6.90
1.2
1.3
u/l
60.1
538.4
0.79
34
98
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
236
1277
1.46
6.89
1.2
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
163
815
1.58
6.88
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1489
10179
1.17
6.88
3.0
4.0
ug/l
37.0
22.7
0.88
1310
8530
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
977
9084
0.83
6.85
1.3
1.2
u/ml
36.6
15.5
1.66
293
2907
(3004809) Band form neutrophils/100 leukocytes in Blood
282
1580
1.41
6.83
2.9
3.6
%
1.2
1.6
1.60
217
1181
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
173
879
1.55
6.82
1.3
1.3
nmol/l
5.7
2.1
0.32
164
837
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
214
2432
0.69
6.82
1.0
1.1
—
—
—
0
0
(4094501)
144
1764
0.64
6.66
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
67
261
2.02
6.57
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
2638
18822
1.13
6.55
7.0
6.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
4403
36865
0.90
6.51
4.9
4.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
53
190
2.20
6.43
1.1
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
167
854
1.54
6.43
1.3
1.7
g/l
0.9
0.9
0.18
129
636
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
85
1173
0.57
6.41
1.7
1.5
nmol/l
51.5
51.8
0.03
79
1087
(3041918) Cholesterol [Moles/volume] in Pleural fluid
57
211
2.13
6.39
1.2
1.2
mmol/l
1.4
1.4
0.25
46
124
(37021550) Renin [Units/volume] in Plasma --upright
45
151
2.34
6.35
1.0
1.3
mu/l
61.7
78.4
0.27
31
104
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
47
161
2.30
6.34
1.0
1.2
pmol/l
236.6
255.7
0.22
30
119
(4035726)
1046
6991
1.19
6.33
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
55
860
0.50
6.29
1.6
1.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
171
885
1.52
6.25
1.3
1.3
nmol/l
0.2
0.4
1.04
19
72
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
80
338
1.86
6.23
1.2
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
183
964
1.50
6.16
2.5
3.6
%
63.9
58.6
2.44
121
582
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
186
985
1.49
6.10
2.8
3.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
2744
23495
0.89
6.08
1.8
1.6
nmol/l
18.2
19.9
4.01
2358
19787
(3026470) Cobalt [Mass/volume] in Blood
47
762
0.48
6.00
1.7
1.9
ug/l
4.7
3.6
0.41
40
660
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3613
30453
0.90
5.94
2.3
2.1
nmol/l
77.0
80.1
6.74
3060
25956
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
149
758
1.55
5.91
1.1
1.2
u/ml
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
31
90
2.71
5.88
1.1
1.1
iu/ml
22.3
12.6
0.41
13
33
(3025577) Chromium [Mass/volume] in Blood
46
744
0.48
5.85
1.7
2.0
ug/l
2.3
2.0
0.32
37
606
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
337
1997
1.33
5.83
1.9
2.2
g/l
3.9
3.6
1.86
316
1886
(3002582) Erythrocytes [#/volume] in Urine
3805
27873
1.10
5.73
4.0
3.6
e6/l
133.4
121.3
0.13
3075
21975
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
10
12
6.55
5.64
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
912
6092
1.19
5.57
4.5
3.2
g/l
125.3
126.6
1.02
885
5925
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
682
6420
0.82
5.47
3.8
2.9
ml/min/173m2
55.7
57.0
0.42
346
2863
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
24
63
3.00
5.44
1.0
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
2201
18973
0.89
5.41
4.8
4.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
291
1710
1.34
5.36
1.5
1.7
mg/l
12.7
12.6
0.05
259
1560
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
132
1562
0.66
5.28
1.2
1.3
mg/l
531.6
595.4
0.88
123
1464
(3044416) Complement C4 [Mass/volume] in Pleural fluid
22
56
3.09
5.25
1.1
1.2
g/l
0.1
0.1
0.49
17
41
(3000919) Neutrophils/100 leukocytes in Pleural fluid
82
370
1.75
5.23
1.4
1.4
%
20.6
18.8
0.22
71
328
(3051651) Icteric interference index of Serum or Plasma
110
539
1.61
5.17
4.7
3.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1383
9605
1.15
5.15
2.2
2.5
e9/l
73.6
66.0
11.66
1035
7410
(3045414) Leukocytes [Presence] in Urine
344
3464
0.77
5.10
2.2
2.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
37
613
0.47
5.10
1.1
1.0
ng/l
33.3
44.8
1.54
28
373
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
37
613
0.47
5.10
1.1
1.0
ng/l
752.4
681.0
0.52
27
367
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
37
612
0.47
5.08
1.1
1.0
ng/l
263.8
336.2
1.29
28
377
(3000330) Specific gravity of Urine by Test strip
529
5063
0.81
5.04
4.9
3.9
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
161
868
1.46
4.92
4.4
3.4
umol/l
317.8
325.1
0.29
137
697
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
41
149
2.16
4.90
1.4
1.4
%
71.4
74.9
0.27
30
123
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1017
6933
1.17
4.88
3.9
3.8
ng/l
113.0
100.5
2.30
831
5755
(3035947) Staphylolysin Ab [Units/volume] in Serum
90
429
1.65
4.75
1.1
1.1
iu/ml
2.3
5.3
—
7
19
(40768793) Breast Pathology biopsy report
85
1077
0.62
4.70
1.4
1.3
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
44
168
2.06
4.66
1.3
1.4
%
23.1
21.1
0.17
35
126
(40762365) Oxygen content in Arterial blood by calculation
44
170
2.04
4.53
2.4
2.7
ml/dl
14.5
14.6
0.10
39
156
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
119
615
1.52
4.50
1.1
1.1
iu/ml
2.1
2.1
0.01
13
29
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
435
2768
1.24
4.42
1.7
2.4
g/l
0.0
0.0
0.00
394
2503
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
687
4578
1.19
4.37
3.3
2.5
%
0.7
0.7
0.14
676
4388
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
22
63
2.75
4.34
1.3
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
4702
35111
1.08
4.31
6.3
4.3
ng/l
89.9
95.3
0.08
3884
28508
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
214
1245
1.36
4.30
1.7
1.5
iu/l
3.7
4.2
0.30
58
322
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
27
87
2.44
4.26
1.1
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
35
127
2.17
4.24
1.2
1.2
ug/l
99.6
108.1
0.15
24
73
(3042010) Triglyceride [Moles/volume] in Pleural fluid
41
159
2.03
4.20
1.2
1.3
mmol/l
0.3
1.6
1.82
29
96
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
440
2822
1.23
4.17
1.7
2.4
g/l
0.0
0.0
0.06
395
2513
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1103
9763
0.88
4.13
1.2
1.2
iu/ml
53.3
43.1
0.94
383
2858
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
118
1353
0.68
4.11
1.2
1.2
mmol/l
4.1
3.9
0.79
108
1250
(3028026) IgM [Mass/volume] in Serum or Plasma
588
3887
1.20
4.11
1.6
1.9
g/l
1.6
1.4
0.72
518
3419
(3005719) IgG [Mass/volume] in Serum or Plasma
723
4873
1.18
4.05
2.3
2.7
g/l
10.7
10.8
0.19
651
4395
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
118
1348
0.68
4.04
1.3
1.4
e6/l
2265.9
2579.6
0.05
94
1116
(3022145) Colonoscopy Study observation
924
8264
0.87
4.04
1.3
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
118
1347
0.68
4.03
1.2
1.3
e6/l
51.0
24.6
0.34
88
1061
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
9
10
7.07
4.02
1.0
1.1
g/l
0.2
0.2
—
9
10
(3018418) pH of Serum or Plasma
3552
26282
1.09
4.01
4.4
4.1
ph
7.4
7.4
0.94
739
4914
(21494755) Public health laboratory ask at order entry panel
20
379
0.41
4.01
1.3
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
3798
28184
1.08
3.99
3.8
3.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
19
53
2.82
3.95
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
108
1239
0.68
3.81
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
622
5706
0.85
3.81
3.4
3.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
174
1001
1.37
3.80
4.3
3.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
387
2476
1.23
3.79
1.4
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
490
3216
1.20
3.74
1.6
2.3
g/l
35.2
37.0
8.48
411
2653
(40757373) Influenza virus identified in Isolate
44
184
1.88
3.69
1.5
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5881
44468
1.07
3.69
8.3
6.6
mmol/l
1.2
1.2
27.09
4887
36915
(40760888) Immunoglobulin light chains.free panel - Serum
432
2805
1.22
3.68
2.0
3.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
61
284
1.69
3.61
2.0
2.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1338
9489
1.12
3.60
2.8
2.5
ug/l
5.6
6.7
2.56
1077
8021
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
492
3243
1.20
3.60
3.1
3.1
pmol/l
4.2
4.3
0.76
419
2777
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
546
3633
1.19
3.59
1.9
3.2
ratio
2.3
3.7
0.83
29
281
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
461
3024
1.20
3.55
1.7
2.4
g/l
0.0
0.1
1.85
416
2700
(3034860) Kappa light chains.free [Mass/volume] in Serum
560
3743
1.18
3.51
1.9
3.2
mg/l
74.3
76.2
0.04
431
3067
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
274
1702
1.27
3.51
2.2
2.3
%
229.2
212.5
2.16
254
1607
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
559
3736
1.18
3.51
1.9
3.2
mg/l
41.2
51.5
1.56
429
3061
(3037522) Nuclear Ab [Titer] in Serum
1088
7645
1.13
3.43
1.3
1.3
titre
542.3
498.1
0.35
266
1726
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
53
2.67
3.42
1.3
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
53
2.67
3.42
1.3
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
53
2.67
3.42
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
467
4340
0.84
3.37
1.1
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
17
49
2.73
3.36
1.1
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
289
1818
1.25
3.34
2.0
2.0
%
84.5
85.7
0.48
274
1725
(3014271) Vancomycin [Susceptibility]
132
744
1.40
3.31
3.5
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1916
13910
1.10
3.28
4.8
4.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1058
7455
1.13
3.20
1.9
2.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
702
4819
1.15
3.16
6.6
4.0
%
45.1
46.1
0.53
690
4753
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
415
2731
1.20
3.14
1.4
1.6
u/l
36.0
37.5
0.70
350
2257
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
31
122
2.00
3.14
1.2
1.1
u/l
17.0
18.1
0.21
20
80
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
42
184
1.79
3.11
1.4
1.5
ug/l
0.3
0.4
0.65
24
101
(3046861) Legionella sp Ag [Presence] in Urine
18
56
2.53
3.10
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
276
1746
1.25
3.07
1.5
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
48
220
1.72
3.06
1.3
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
93
500
1.46
3.04
1.1
1.2
titre
175.0
154.7
0.07
12
88
(3001019) Free T4 and TSH panel - Serum or Plasma
35
490
0.56
3.00
1.6
1.6
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
44
199
1.74
2.95
1.0
1.1
u/ml
5.1
2.6
—
7
22
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
69
352
1.54
2.91
1.8
1.9
e9/l
0.3
0.2
0.77
64
316
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
48
224
1.69
2.89
1.6
1.6
nmol/l
6.5
6.5
0.00
41
192
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
576
3927
1.16
2.88
1.6
2.3
g/l
10.2
10.4
0.45
484
3196
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
244
1536
1.25
2.87
1.1
1.3
u/l
31.2
40.1
0.95
204
1325
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
519
3512
1.17
2.86
1.7
2.5
g/l
0.9
1.2
0.76
433
2898
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
144
846
1.34
2.85
1.8
1.7
u/ml
30.4
26.9
0.33
38
191
(3043410) Blood group antigens tested for on Red Blood Cells
52
249
1.64
2.85
2.0
1.9
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
118
672
1.38
2.84
1.4
1.4
titre
66.4
60.4
0.10
11
50
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
222
2174
0.80
2.78
3.2
4.3
u/ml
96.3
95.1
0.02
213
2078
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
49
233
1.65
2.76
1.1
1.2
iu/ml
276.2
184.9
0.42
49
227
(3033923) Metanephrine [Moles/time] in 24 hour Urine
33
140
1.85
2.73
1.0
1.2
umol/24h
0.7
0.6
0.10
14
57
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
18
301
0.47
2.72
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
83
932
0.70
2.72
1.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
70
811
0.68
2.72
2.1
1.7
pmol/l
177.3
185.9
0.29
58
727
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
562
3846
1.15
2.69
1.6
2.4
g/l
3.3
3.1
5.97
450
2909
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
29
119
1.92
2.66
1.1
1.2
—
10.6
—
0
8
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
26
103
1.98
2.63
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
82
2.11
2.60
1.0
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
2869
21366
1.07
2.58
2.0
1.8
nmol/l
1110.7
1155.3
1.69
2108
15734
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
78
876
0.70
2.58
1.1
1.2
—
—
—
0
0
(44813793)
56
281
1.57
2.57
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
101
573
1.39
2.53
1.6
1.7
%
9.5
10.8
1.92
101
573
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
27
385
0.55
2.53
1.3
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
70
371
1.48
2.52
1.8
1.9
e6/l
448.4
488.7
0.29
63
315
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
20
73
2.15
2.49
1.3
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
19
68
2.20
2.48
1.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
16
53
2.37
2.47
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3395
25460
1.07
2.47
3.9
3.5
e6/l
0.7
0.5
3.40
2686
19734
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
52
0.00
2.46
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
152
0.36
2.44
1.3
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2001
14747
1.08
2.40
3.7
3.3
e6/l
2.9
1.7
5.16
1148
8538
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
602
4177
1.14
2.40
1.6
2.3
g/l
3.9
3.8
0.69
447
2857
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
603
4188
1.14
2.37
1.6
2.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
124
1275
0.76
2.36
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
715
6262
0.89
2.35
2.1
1.9
ug/g
194.7
173.0
0.55
561
4680
(3018095) Leukocytes [#/volume] in Urine
4107
31017
1.06
2.35
4.6
4.0
e6/l
130.0
128.3
0.04
3183
23224
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
118
696
1.33
2.34
1.4
1.4
titre
271.3
303.3
0.10
16
79
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
26
108
1.89
2.33
1.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
603
4194
1.14
2.33
1.6
2.3
g/l
7.9
7.4
8.78
457
2966
(3017509) Phencyclidine [Presence] in Urine
5
6
6.55
2.33
1.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
297
1957
1.20
2.31
2.2
2.6
mg/l
2.1
1.8
3.64
252
1718
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
66
353
1.47
2.30
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
243
2304
0.82
2.29
1.0
1.1
u/ml
1.0
1.2
—
5
34
(3044290) Cell count panel - Cerebral spinal fluid
118
1214
0.76
2.27
1.2
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
3207
24067
1.06
2.26
3.9
3.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
196
1894
0.81
2.24
2.8
2.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
463
3175
1.15
2.22
2.6
2.8
g/l
0.4
0.3
0.57
196
1332
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
46
551
0.65
2.18
1.1
1.1
—
3.5
—
0
8
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
48
567
0.66
2.13
1.2
1.2
mmol/l
7.6
8.1
0.67
30
369
(3032743) Legionella sp IgG Ab [Presence] in Serum
13
42
2.43
2.13
1.1
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
13
42
2.43
2.13
1.1
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
48
245
1.54
2.11
1.5
1.8
u/ml
931.9
47369.4
—
10
38
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
11
33
2.62
2.07
1.0
1.0
pmol/l
119.4
109.1
—
5
19
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
40
197
1.60
2.05
1.2
1.5
%
6.8
10.2
0.60
22
93
(3020491) Glucose [Moles/volume] in Blood
98
576
1.34
2.04
2.8
2.1
mmol/l
7.5
7.3
0.18
72
391
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
74
800
0.72
2.03
1.1
1.2
u/ml
272.1
291.0
0.21
42
473
(40768443) Skin Pathology biopsy report
411
3688
0.87
2.02
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
379
2583
1.16
2.01
1.5
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
698
4951
1.11
1.98
1.6
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
163
0.43
1.97
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
356
0.59
1.97
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
143
890
1.26
1.97
1.2
1.4
mu/l
76.5
63.0
0.48
121
773
(3032057) Clostridioides difficile [Presence] in Stool
46
237
1.53
1.96
1.8
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
303
2772
0.85
1.95
1.1
1.2
iu/ml
103.7
111.6
0.13
82
880
(4198724)
13
44
2.32
1.95
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
608
5307
0.89
1.93
2.8
2.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
67
728
0.72
1.92
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
104
1058
0.77
1.90
1.3
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
61
336
1.43
1.89
1.1
1.1
u/ml
1.2
1.6
0.24
20
129
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
66
369
1.41
1.88
1.1
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
98
584
1.32
1.88
1.8
1.9
e9/l
1.0
1.0
0.09
60
367
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
155
981
1.24
1.86
2.0
2.3
u/ml
305.6
1137.4
1.33
150
962
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
45
521
0.68
1.85
1.1
1.1
—
58.0
—
0
10
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
60
331
1.43
1.85
1.0
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
755
5402
1.10
1.84
3.6
3.0
e6/l
0.3
0.3
0.16
736
5330
(3000764) Benzodiazepines [Presence] in Urine
24
106
1.78
1.84
1.1
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
144
0.44
1.84
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
107
1.76
1.79
1.1
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
108
0.36
1.78
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
205
0.50
1.77
1.1
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
35
174
1.58
1.76
2.3
2.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
228
1510
1.19
1.76
3.9
2.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
195
1273
1.21
1.76
1.2
1.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
22
96
1.80
1.76
1.0
1.2
ng/l
164.4
1070.2
0.57
11
66
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
209
1374
1.20
1.75
3.4
3.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
65
368
1.39
1.75
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
114
703
1.28
1.73
1.4
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
65
369
1.39
1.73
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
65
369
1.39
1.73
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
65
695
0.73
1.72
1.2
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
132
830
1.25
1.71
1.1
1.3
pmol/l
231.0
256.0
0.39
99
620
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
192
0.49
1.71
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
24
109
1.73
1.69
1.1
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
84
861
0.76
1.67
1.0
1.1
iu/ml
7.0
544.0
0.98
12
153
(3019832) Treponema pallidum Ab [Presence] in Serum
150
1436
0.82
1.66
1.3
1.3
—
—
—
0
0
(4211845)
41
471
0.68
1.65
4.0
3.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
24
110
1.71
1.65
1.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
111
688
1.27
1.63
1.4
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
29
141
1.62
1.62
12.5
12.2
mmol/l
4.8
5.6
1.01
29
141
(3048929) Epstein Barr virus Ab [Presence] in Serum
107
1059
0.79
1.62
1.1
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
12
43
2.19
1.61
2.7
1.4
mmol/l
23.3
23.5
—
7
22
(3022493) Free Hemoglobin [Mass/volume] in Plasma
65
374
1.37
1.61
2.0
3.4
mg/l
99.6
70.0
0.92
43
255
(40761539) Cells [Type] in Urine sediment by Light microscopy
46
249
1.45
1.60
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
64
368
1.37
1.60
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
64
368
1.37
1.60
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
187
0.50
1.60
1.1
1.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
16
65
1.93
1.59
1.7
2.0
%
18.9
10.5
—
8
40
(3001964) Herpes simplex virus Ag [Presence] in Specimen
34
173
1.54
1.58
1.2
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
186
0.51
1.58
1.1
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
16
226
0.56
1.56
1.1
1.1
u/l
1.1
1.1
—
6
117
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
35
180
1.53
1.56
1.3
1.8
%
29.3
29.7
0.05
35
159
(4024509)
88
887
0.78
1.56
2.0
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
30
360
0.65
1.53
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
709
5111
1.09
1.52
1.5
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
89
892
0.78
1.51
1.4
1.3
u/ml
122.6
124.2
0.05
17
209
(3026389) Candida sp identified in Specimen by Organism specific culture
144
929
1.22
1.51
1.3
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
144
1368
0.82
1.50
1.3
1.3
nmol/l
1.0
0.8
2.33
116
1106
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
15
213
0.55
1.50
1.3
1.2
nmol/l
88.5
137.9
—
10
160
(3011335) Digoxin [Mass/volume] in Serum or Plasma
24
114
1.65
1.48
2.9
2.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
171
0.50
1.47
1.1
1.1
—
—
—
0
0
(44806071)
12
45
2.09
1.47
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
309
0.63
1.47
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
58
613
0.74
1.47
1.2
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
232
1568
1.16
1.46
1.5
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
122
1174
0.81
1.46
1.1
1.1
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
5
12
3.27
1.45
12.2
6.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
180
0.52
1.44
1.2
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
68
1.85
1.42
1.5
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
31
2.28
1.40
2.0
1.5
umol/l
16.2
17.4
—
9
31
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
389
3404
0.89
1.38
2.8
3.1
u/ml
2319.1
2224.0
0.02
342
2908
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
187
0.55
1.38
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3893
29697
1.04
1.37
2.8
2.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
39
434
0.70
1.37
4.1
4.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
120
771
1.22
1.34
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
14
58
1.90
1.34
1.0
1.1
umol/24h
2.1
1.7
0.92
14
58
(3011325) HIV 1+2 Ab [Presence] in Serum
6
18
2.62
1.33
1.0
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
18
2.62
1.33
1.0
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
131
851
1.21
1.32
1.2
1.3
u/l
11.3
11.8
0.15
97
666
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
73
733
0.78
1.30
1.4
1.8
mg/l
5.2
4.7
0.49
65
684
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
40
438
0.72
1.30
1.1
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
162
0.53
1.27
1.1
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
4281
32769
1.04
1.26
4.0
3.6
—
1.0
—
0
5
(3041184) Isoniazid [Presence] in Urine
5
14
2.80
1.26
3.6
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
352
0.69
1.24
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
23
277
0.65
1.24
1.2
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
72
441
1.28
1.23
1.5
1.8
%
15.4
16.9
0.40
34
156
(4281824)
66
665
0.78
1.23
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
26
304
0.67
1.22
1.0
1.1
mg/l
42.6
48.4
0.33
21
254
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
17
78
1.71
1.21
1.8
2.0
%
57.7
67.0
—
9
57
(3034274) Bile acid [Moles/volume] in Serum --fasting
43
245
1.38
1.20
1.2
1.2
umol/l
8.5
16.8
1.13
28
173
(3024263) Appearance of Synovial fluid
75
464
1.27
1.20
1.5
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
12
168
0.56
1.19
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
349
3041
0.90
1.19
5.5
4.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
21
103
1.60
1.18
1.1
1.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
100
0.47
1.18
1.7
2.9
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
27
0.00
1.18
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
22
264
0.65
1.18
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
34
375
0.71
1.17
2.1
2.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
15
2.62
1.17
1.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
157
0.55
1.17
1.0
1.1
miu/ml
1516.8
1721.4
0.21
11
157
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
33
365
0.71
1.16
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
73
453
1.27
1.15
1.1
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
21
104
1.59
1.15
1.4
1.8
e6/l
70.0
2055.0
1.38
16
48
(44816559) Phosphatidylethanol [Mass/volume] in Blood
118
774
1.20
1.12
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
599
5071
0.92
1.11
3.2
2.9
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
39
222
1.38
1.11
1.3
1.4
g/l
17.0
14.3
1.17
30
170
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2298
17417
1.04
1.10
3.4
3.1
mmol/l
2.5
2.5
21.84
1922
15065
(3045142) Bone marrow Pathology biopsy report
115
1074
0.84
1.08
1.2
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
25
2.20
1.08
2.0
2.6
—
—
—
0
0
(3036489) Thrombin time
356
2538
1.10
1.05
1.9
1.8
s
23.0
22.0
0.92
326
2310
(3019420) Tryptase [Mass/volume] in Serum or Plasma
21
247
0.67
1.05
1.1
1.5
ug/l
12.0
9.5
0.19
16
224
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
12
52
1.81
1.04
1.3
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
36
1.96
1.03
1.7
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4909
39305
0.97
1.02
3.8
3.1
u/l
64.5
58.7
2.82
4409
34889
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
76
482
1.24
1.02
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
76
482
1.24
1.02
1.3
1.4
—
—
—
0
0
(4146454)
124
1142
0.85
1.01
2.6
2.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
64
399
1.26
1.00
2.0
2.0
e6/l
717.2
507.4
1.20
33
167
(3006270) Folate [Moles/volume] in Blood
92
869
0.83
1.00
1.3
1.2
nmol/l
274.2
304.5
0.76
62
645
(3034426) Prothrombin time (PT)
27
147
1.44
1.00
1.1
1.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
24
0.00
0.99
0.0
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
54
539
0.79
0.98
1.3
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
52
521
0.78
0.98
2.4
2.1
umol/l
16.5
36.7
—
9
43
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
636
5338
0.93
0.97
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
167
0.61
0.97
1.5
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
15
186
0.63
0.97
1.1
1.1
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
26
0.00
0.96
0.0
1.0
—
360.8
—
0
10
(3045683) HLA typing for celiac disease panel - Blood or Tissue
17
204
0.65
0.95
1.1
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
19
97
1.54
0.95
4.8
5.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
41
243
1.33
0.94
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
430
0.77
0.94
1.1
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
81
0.48
0.90
1.2
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
83
0.47
0.90
1.6
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
13
61
1.67
0.89
1.8
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
3456
26505
1.03
0.89
3.0
2.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
144
984
1.15
0.89
1.2
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
22
118
1.46
0.89
1.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
27
151
1.40
0.89
1.0
1.0
u/ml
0.5
1.6
—
8
64
(3051387) C reactive protein [Mass/volume] in Capillary blood
282
2009
1.10
0.89
5.0
3.7
mg/l
35.0
31.0
0.98
210
1334
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
40
408
0.77
0.88
1.0
1.1
nmol/l
1.6
10.2
—
6
92
(3037556) Urate [Mass/volume] in Serum or Plasma
28
301
0.73
0.88
1.3
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
21
112
1.47
0.87
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
73
471
1.22
0.87
4.5
3.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
185
1288
1.13
0.87
3.4
2.1
mg/l
33.5
28.2
0.54
58
307
(3011288) Drugs identified in Urine by Screen method
15
74
1.59
0.87
1.2
1.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
49
485
0.79
0.86
1.1
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
290
0.73
0.85
1.6
1.9
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
109
0.58
0.84
1.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
110
0.57
0.84
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
27
153
1.39
0.83
1.6
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
67
432
1.22
0.82
1.5
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
118
801
1.16
0.82
1.3
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
11
140
0.62
0.82
1.8
2.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
11
140
0.62
0.82
1.8
2.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
211
1490
1.11
0.80
1.1
1.1
titre
487.7
964.4
1.35
13
41
(40762887) Creatinine [Moles/volume] in Blood
0
19
0.00
0.80
0.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
27
286
0.74
0.80
1.1
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
11
51
1.69
0.79
2.7
4.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
105
956
0.86
0.79
3.5
3.3
nmol/l
10.9
9.4
0.17
99
933
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
76
499
1.20
0.79
1.8
1.7
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
22
0.00
0.78
0.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
42
417
0.79
0.78
4.3
5.0
u/ml
103.3
89.7
—
9
120
(3021589) Normoblasts [#/volume] in Blood
4014
32121
0.97
0.78
14.1
10.7
e9/l
0.0
0.0
0.29
3194
26116
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
71
666
0.84
0.77
1.2
1.2
nmol/l
1.7
1.4
1.15
60
593
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
128
0.61
0.77
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
129
887
1.14
0.76
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
15
174
0.68
0.75
1.3
2.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
130
1159
0.88
0.74
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
148
1030
1.13
0.74
1.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
19
2.07
0.74
1.2
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
9
43
1.64
0.73
4.6
3.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
28
164
1.34
0.73
1.0
1.0
u/ml
8.7
1.3
—
9
72
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
173
0.68
0.73
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
191
1662
0.90
0.73
1.5
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
246
1763
1.10
0.73
1.4
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
27
281
0.75
0.72
1.1
1.2
%
68.0
57.1
—
5
35
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
27
158
1.34
0.71
1.6
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
208
1798
0.91
0.71
1.2
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
23
244
0.74
0.71
18.3
24.4
ug/l
102.5
101.2
0.03
15
207
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
7
32
1.72
0.70
1.9
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
44
277
1.25
0.70
1.2
1.5
iu/l
26.9
27.3
0.02
30
225
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
92
1.45
0.69
1.1
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
24
139
1.36
0.68
1.3
1.3
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
33
1.67
0.68
2.4
2.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
97
661
1.15
0.68
1.1
1.2
u/ml
3.8
5.1
0.29
36
219
(3002523) Influenza virus A Ag [Presence] in Specimen
39
243
1.26
0.68
1.2
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
20
215
0.73
0.67
2.7
6.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
37
364
0.80
0.66
1.9
2.6
%
46.8
34.6
2.93
18
130
(4268621)
63
415
1.19
0.66
2.0
2.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
11
132
0.65
0.66
1.1
1.2
—
500.0
—
0
6
(3022689) Creatine [Moles/volume] in Urine
21
223
0.74
0.66
1.5
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
18
196
0.72
0.66
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
159
1122
1.11
0.66
1.6
1.5
%
67.5
63.8
0.66
106
705
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
26
266
0.77
0.64
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
483
3578
1.06
0.64
1.3
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
90
614
1.15
0.63
1.3
1.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
83
0.57
0.62
1.0
1.1
—
—
—
0
0
(4212803)
18
101
1.40
0.62
1.1
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
18
101
1.40
0.62
1.1
1.1
nmol/l
7.7
8.9
0.25
13
90
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
184
1315
1.10
0.61
3.0
3.9
iu/ml
565.5
2618.2
0.80
23
185
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
110
0.64
0.61
1.1
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
67
448
1.18
0.61
1.2
1.2
mmol/l
12.3
12.0
0.07
22
141
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.61
0.0
1.0
—
11746.6
—
0
5
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
8
40
1.57
0.60
1.5
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
22
129
1.34
0.60
1.0
1.0
u/ml
0.2
0.1
—
6
46
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
18
0.00
0.60
0.0
1.1
—
0.0
—
0
10
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
78
530
1.16
0.59
1.7
2.1
u/field
1.8
2.5
0.71
52
350
(3036670) Protein [Mass/volume] in Synovial fluid
51
334
1.20
0.59
1.2
1.2
g/l
40.4
40.4
0.01
29
163
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
7
89
0.62
0.59
2.0
4.7
ug/min
62.4
59.7
—
7
76
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
93
641
1.14
0.58
1.1
1.2
u/ml
2.9
4.3
1.44
51
287
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
41
263
1.22
0.58
2.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
2715
21752
0.97
0.58
3.1
3.0
umol/l
5382.2
7019.4
0.91
2239
18075
(3044009) aPTT.lupus sensitive (LA screen)
8
42
1.50
0.57
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
125
879
1.12
0.57
1.9
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
168
1201
1.10
0.57
1.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
294
2471
0.93
0.56
2.2
2.3
ug/min
180.5
112.3
1.63
158
1392
(3008401) Mugwort IgE Ab [Units/volume] in Serum
44
286
1.21
0.55
1.0
1.0
u/ml
0.2
1.3
1.95
14
118
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
245
1786
1.08
0.54
1.6
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
44
287
1.20
0.54
1.0
1.0
u/ml
0.6
2.1
1.79
14
120
(3038177) Helicobacter pylori Ab [Presence] in Serum
102
713
1.12
0.53
1.4
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
214
0.77
0.53
1.4
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
104
0.68
0.52
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
75
516
1.14
0.50
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
75
516
1.14
0.50
1.2
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
36
341
0.83
0.49
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
84
0.65
0.49
1.4
1.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
85
0.65
0.49
1.3
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
58
524
0.87
0.47
1.2
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
37
347
0.84
0.47
1.1
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
80
557
1.13
0.46
1.2
1.2
u/ml
70.4
66.8
—
7
19
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
5
64
0.61
0.46
2.6
2.0
mg/l
8.7
8.0
—
5
50
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
47
430
0.86
0.45
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
33
214
1.21
0.45
1.4
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
40
265
1.19
0.44
1.1
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
3653
29071
0.98
0.44
3.3
3.3
mmol/l
2.3
2.3
4.51
3056
24380
(3014765) Yersinia sp identified in Stool by Organism specific culture
273
2020
1.06
0.43
1.2
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
32
208
1.21
0.43
1.0
1.0
u/ml
0.5
0.6
—
8
47
(3006922) Hepatitis E virus Ab [Presence] in Serum
36
335
0.84
0.43
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
162
1177
1.08
0.43
1.3
2.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
73
0.65
0.43
3.0
4.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
110
0.71
0.42
1.0
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
12
0.00
0.42
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
12
0.00
0.42
0.0
1.1
—
4747.5
—
0
12
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.42
0.0
1.1
—
2.1
—
0
12
(3025315) Body weight
12
68
1.39
0.42
6.2
5.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
241
2011
0.94
0.41
2.5
3.0
u/ml
3029.5
965.2
0.37
213
1824
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
13
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
68
601
0.89
0.41
1.6
2.0
min
496.3
499.9
0.09
37
416
(3007566) Smooth muscle Ab [Titer] in Serum
203
1491
1.07
0.41
1.1
1.1
titre
122.6
119.3
0.03
19
106
(42529406) Shigella sp [Presence] in Stool by Culture
273
2025
1.06
0.41
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
34
224
1.19
0.41
1.1
1.1
ratio
1.1
1.1
0.19
13
64
(3006567) Chloride [Moles/time] in 24 hour Urine
0
14
0.00
0.41
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
118
0.73
0.41
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
270
2003
1.06
0.40
1.2
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
16
96
1.31
0.40
1.8
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
205
0.80
0.40
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
15
0.00
0.40
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
330
2467
1.05
0.38
1.4
1.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
28
1.40
0.38
1.0
1.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
10
56
1.40
0.37
6.7
6.7
umol/l
0.5
0.3
—
5
48
(3042733) HLA Ab [Presence] in Serum
10
107
0.73
0.37
6.7
4.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
281
2096
1.05
0.36
1.7
1.6
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
5
62
0.63
0.36
1.0
2.4
—
129.2
—
0
20
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3910
30366
1.02
0.36
3.4
2.9
ug/l
169.4
171.2
0.09
3476
27006
(3008037) Lactate [Moles/volume] in Venous blood
342
2568
1.05
0.35
6.2
3.4
mmol/l
1.7
1.7
0.41
335
2509
(3019225) pH of Specimen
1177
9452
0.98
0.34
4.9
4.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
17
106
1.26
0.34
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
879
6724
1.03
0.34
5.0
4.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
10
105
0.75
0.33
1.4
2.7
pmol/l
73.6
78.8
—
10
97
(3015171) Extractable nuclear Ab [Units/volume] in Serum
281
2104
1.05
0.33
1.2
1.2
u/ml
0.7
0.8
0.04
35
214
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
35
237
1.16
0.33
3.6
2.5
mmol/l
7.0
8.0
1.16
19
160
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
23
150
1.20
0.32
1.2
1.2
g/l
0.3
0.3
0.13
15
115
(3032773) Endomysium IgG Ab [Titer] in Serum
50
441
0.89
0.32
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
83
712
0.91
0.32
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
20
190
0.83
0.32
1.5
1.3
nmol/l
0.1
0.1
0.20
13
146
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
42
290
1.14
0.31
2.0
2.1
umol/l
68.6
56.8
1.77
30
219
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
76
0.72
0.31
1.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
7
42
1.31
0.30
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
144
1061
1.07
0.30
1.5
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
104
880
0.93
0.30
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
130
1.21
0.29
1.2
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
14
87
1.26
0.29
3.8
3.1
mg/l
1.2
1.2
—
9
74
(3038026) Centromere Ab [Units/volume] in Serum
80
577
1.09
0.29
1.2
1.2
u/ml
55.0
50.5
—
6
21
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
148
1095
1.06
0.28
1.5
1.4
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
25
229
0.86
0.28
1.2
1.2
%
31.0
33.5
0.12
14
148
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
49
1.28
0.28
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
24
220
0.86
0.27
3.2
2.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
166
1236
1.06
0.26
1.3
1.2
u/ml
2.3
6.5
1.06
20
81
(3027923) C peptide [Moles/volume] in Serum or Plasma
45
393
0.90
0.26
1.2
1.3
nmol/l
1.7
1.2
1.55
30
294
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
59
0.67
0.26
1.6
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
117
978
0.94
0.26
1.3
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
23
154
1.17
0.26
1.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
143
1061
1.06
0.26
1.5
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
26
235
0.87
0.25
1.5
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
38
266
1.12
0.25
1.7
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
68
579
0.92
0.25
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
143
1064
1.06
0.24
1.5
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
16
150
0.84
0.24
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
78
569
1.08
0.23
2.2
2.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
97
812
0.94
0.23
3.2
3.1
mg/l
73.4
42.1
0.67
80
602
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
198
1488
1.05
0.23
1.3
1.2
u/ml
11.3
48.0
3.71
15
71
(3029075) Extractable nuclear Ab panel - Serum
23
156
1.16
0.23
1.0
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
24
164
1.15
0.22
1.4
1.2
mg/l
217.7
1.0
0.48
18
127
(3010838) Calcium [Moles/time] in 24 hour Urine
39
339
0.90
0.22
1.4
1.7
—
6.4
—
0
16
(3024471) HLA-A [Type]
12
115
0.82
0.22
1.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
11
69
1.25
0.22
1.1
1.1
u/l
16.3
12.2
0.25
11
69
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2595
20177
1.01
0.22
2.9
2.5
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
8
0.00
0.22
0.0
1.1
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
8
0.00
0.22
0.0
2.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.22
0.0
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
9
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
189
1423
1.04
0.21
1.3
1.2
u/ml
6.1
4.7
0.37
43
215
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
11
0.00
0.20
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
11
0.00
0.20
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
11
0.00
0.20
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
11
0.00
0.20
0.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3437
27193
0.99
0.20
2.3
2.2
u/l
287.0
229.0
1.28
3197
25255
(3013293) Extractable nuclear Ab [Presence] in Serum
12
77
1.22
0.20
2.0
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
57
414
1.08
0.20
1.2
1.5
umol/l
19.3
15.3
2.03
51
381
(3019897) Erythrocyte distribution width [Ratio] by Automated count
9
91
0.78
0.20
27.2
8.0
%
14.9
13.6
—
9
91
(3028433) Virus identified in Specimen by Culture
33
233
1.11
0.20
1.3
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
39
1.21
0.20
6.8
9.3
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
23
205
0.88
0.20
1.3
1.3
g/l
27.2
55.2
0.51
18
165
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1000
7729
1.02
0.20
4.8
3.8
mmol/l
1.2
1.2
7.19
904
6614
(3004775) Volume in Urine collected for unspecified duration
107
885
0.95
0.19
1.9
2.2
ml
715.4
663.2
0.26
53
551
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
42
360
0.92
0.19
1.2
1.5
u/l
16.2
6.3
0.81
30
298
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
43
368
0.92
0.19
1.0
1.0
mg/l
306.9
286.0
0.94
36
319
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
20
137
1.15
0.18
1.2
1.1
%
77.5
79.4
0.09
11
71
(3021879) Hepatitis B virus core Ab [Presence] in Serum
413
3166
1.03
0.18
1.3
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
46
1.19
0.18
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
143
1076
1.04
0.18
1.5
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
14
93
1.18
0.18
1.5
1.2
%
97.4
68.3
—
5
35
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
14
93
1.18
0.18
1.1
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
14
93
1.18
0.18
1.3
1.2
%
95.8
70.1
—
5
34
(3000570) Elastase.pancreatic [Mass/mass] in Stool
310
2368
1.03
0.18
1.4
1.4
ug/g
246.0
254.2
0.31
191
1470
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
112
0.84
0.17
1.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
186
1409
1.04
0.17
1.3
1.2
u/ml
12.7
4.0
0.39
28
135
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
37
317
0.92
0.17
4.9
6.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
177
1340
1.04
0.17
1.3
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
17
153
0.87
0.17
1.2
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
57
418
1.07
0.17
1.4
1.5
%
2.6
3.2
0.19
14
101
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
65
543
0.94
0.17
2.4
2.2
ug/min
118.6
142.8
0.14
14
138
(4027681)
22
194
0.89
0.17
1.1
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
142
1071
1.04
0.17
1.5
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
26
184
1.11
0.16
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
26
184
1.11
0.16
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
26
184
1.11
0.16
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
26
184
1.11
0.16
1.2
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
20
139
1.13
0.15
2.1
1.6
ug/l
9.6
10.3
0.22
20
139
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
160
1301
0.97
0.15
1.3
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
36
306
0.92
0.15
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
36
306
0.92
0.15
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
78
0.81
0.14
1.1
2.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
79
0.80
0.13
1.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
61
453
1.06
0.13
1.1
1.1
%
87.6
91.5
0.63
55
409
(3036071) Salmonella sp Ab [Titer] in Serum
17
118
1.13
0.13
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
591
4710
0.98
0.13
4.2
3.2
e9/l
5.1
4.2
6.56
378
3161
(3020717) Zinc [Moles/volume] in Serum or Plasma
26
223
0.92
0.13
1.2
1.3
umol/l
13.3
20.3
1.32
26
209
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
27
194
1.09
0.13
1.1
1.3
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
182
0.91
0.12
1.0
1.5
iu/ml
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
33
240
1.08
0.12
1.5
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
289
2222
1.02
0.12
1.2
1.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
12
108
0.87
0.12
1.1
1.2
mmol/l
7.1
6.6
—
5
48
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
40
335
0.94
0.12
1.5
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
14
124
0.89
0.11
3.7
4.1
u/l
56.1
40.7
—
8
45
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
74
606
0.96
0.11
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1332
10374
1.01
0.11
1.3
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
27
196
1.08
0.11
1.3
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
33
277
0.94
0.11
1.6
1.7
—
—
—
0
0
(3036603) Volume of Urine
67
549
0.96
0.10
1.4
1.7
ml
1768.3
1895.9
0.31
24
164
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
28
236
0.93
0.10
1.0
1.1
iu/ml
11.0
13.3
—
6
56
(3016650) Hepatitis A virus Ab [Presence] in Serum
108
822
1.03
0.10
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
40
332
0.95
0.10
1.5
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
25
182
1.08
0.09
1.4
1.4
ng/l
110.9
133.8
0.47
25
182
(3038071) Oxygen [Partial pressure] in Mixed venous blood
23
167
1.08
0.09
6.5
9.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
17
146
0.91
0.09
1.0
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
48
394
0.96
0.08
2.0
2.4
ml
1572.3
1848.8
1.22
39
315
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
48
0.82
0.08
1.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
20
145
1.08
0.08
1.3
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
50
1.10
0.08
1.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
50
1.10
0.08
1.0
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
21
153
1.08
0.08
1.1
1.4
—
241.4
—
0
25
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
60
454
1.04
0.07
1.1
1.1
u/ml
16.4
3.6
—
8
84
(3001729) Color of Synovial fluid
13
92
1.11
0.07
1.8
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
35
261
1.05
0.07
1.1
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
59
1.06
0.07
2.3
4.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
24
201
0.94
0.07
1.3
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
138
1.08
0.07
1.2
1.3
%
72.8
74.9
0.07
11
74
(3028717) Thiamine [Mass/volume] in Blood
9
66
1.07
0.07
1.0
1.1
—
—
—
0
0
(4306422)
77
587
1.03
0.07
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
53
401
1.04
0.07
1.2
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
62
471
1.03
0.07
1.2
1.3
u/l
102.5
101.9
0.02
52
408
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
16
136
0.92
0.06
2.4
3.0
u/field
0.4
0.3
0.06
16
136
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
19
139
1.07
0.06
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
25
207
0.95
0.05
7.2
8.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
70
564
0.97
0.05
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
112
896
0.98
0.05
1.8
2.2
u/field
2.0
1.8
0.16
45
307
(3038515) Glucose [Moles/volume] in Venous blood
316
2457
1.01
0.05
6.6
3.5
mmol/l
7.8
7.8
0.01
309
2403
(3048879) Bone marrow aspiration report
42
341
0.97
0.05
1.2
1.5
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
21
156
1.06
0.04
1.1
1.3
—
2781900.0
—
0
6
(3021387) Prolactin [Units/volume] in Serum or Plasma
83
665
0.98
0.04
1.6
1.9
mu/l
269.6
312.0
1.17
75
613
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
34
277
0.96
0.04
1.3
1.8
e6/l
39630.2
16513.6
0.61
21
159
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
43
348
0.97
0.04
4.4
5.3
%
66.9
72.3
0.72
31
276
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
219
1.04
0.03
1.0
1.3
u/l
2.4
15.6
—
8
67
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
74
570
1.02
0.03
1.1
1.1
%
114.1
110.4
0.41
66
484
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
107
852
0.99
0.03
1.6
1.5
%
21.6
25.9
0.80
74
540
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
120
953
0.99
0.02
1.3
1.2
u/ml
51.0
46.0
0.11
17
99
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
32
259
0.97
0.02
2.3
2.8
umol/l
29.7
28.6
0.14
18
197
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
143
1134
0.99
0.02
1.4
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
6299
49494
1.00
0.02
7.0
4.7
mmol/l
7.0
7.0
0.16
6022
46556
(3007164) IgA [Mass/volume] in Serum or Plasma
1343
10567
1.00
0.02
1.4
1.5
g/l
3.3
2.8
4.67
758
5705
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
105
834
0.99
0.02
1.2
1.2
u/l
57.2
64.1
0.47
70
547
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
17
140
0.95
0.02
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
152
1204
0.99
0.02
2.2
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
71
566
0.98
0.02
4.0
2.5
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
53
424
0.98
0.02
1.2
1.1
u/l
23.0
34.8
1.22
37
305
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
53
424
0.98
0.02
1.2
1.1
u/l
94.7
94.2
0.02
37
319
(21494434) Karyotype in Bone marrow
115
912
0.99
0.02
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2006
15729
1.00
0.02
3.5
3.1
e6/l
1.4
1.4
0.06
1155
9450
(3000012) Reticulocyte production index
81
644
0.99
0.02
1.2
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
112
871
1.01
0.02
1.6
1.3
e6/l
166154.1
186999.1
0.08
77
595
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
10
73
1.08
0.02
1.2
1.1
—
37.6
—
0
17
(44806420)
49
378
1.02
0.01
2.4
2.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
132
1029
1.01
0.01
1.8
2.1
u/ml
339.2
8742.9
0.66
11
80
(3023487) Leukocytes [#/volume] in Peritoneal fluid
38
304
0.98
0.01
1.5
2.0
e6/l
16865.5
5475.7
0.31
26
210
(3000475) Leukocytes [#/volume] in Synovial fluid
270
2127
1.00
0.01
1.6
1.6
e6/l
27217.8
14784.4
1.46
193
1504
(3039162) Centromere protein B Ab [Units/volume] in Serum
84
654
1.01
0.01
1.3
1.2
u/ml
49.6
62.8
—
7
37
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
111
877
0.99
0.00
1.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
10
74
1.06
0.00
1.5
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
63
496
1.00
0.00
1.6
1.6
u/l
8.2
7.5
0.05
30
229
(3002619) Bacteria identified in Specimen by Culture
22
174
0.99
0.00
1.3
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
87
0.99
0.00
1.1
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
59
459
1.01
0.00
1.2
1.3
u/l
28.0
30.8
0.21
50
389
(3047007) Chlamydophila sp Ab [Presence] in Serum
66
520
1.00
0.00
1.2
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
43
334
1.01
0.00
3.6
2.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
31
244
1.00
0.00
1.6
1.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
17
134
1.00
0.00
6.4
7.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
269
0.99
0.00
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
68
538
0.99
0.00
1.1
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
86
1.00
0.00
1.1
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
85
669
1.00
0.00
7.1
12.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
29
226
1.01
0.00
1.3
1.1
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.5
—
0
6
(3002719) Hemoglobin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
32.6
—
0
7
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
56
0.98
0.00
1.0
1.0
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
0.4
—
0
7
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
7
56
0.98
0.00
1.1
1.2
u/l
159.0
110.1
—
7
50
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001488) Cow milk IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
3.4
—
0
5
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
65
0.97
0.00
31.0
10.8
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
45
0.87
0.00
1.2
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
57
0.96
0.00
1.1
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
49
0.96
0.00
1.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
6
53
0.89
0.00
1.3
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
65
0.97
0.00
2.0
1.9
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
47
0.84
0.00
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
65
0.97
0.00
1.3
1.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
73
0.97
0.00
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
45
0.87
0.00
1.4
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint COPD_LATER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| COPD_LATER | 2.943 [2.69, 3.22] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.045 |
During the follow-up period (1.1.1998 — 31.12.2019), 14790 out of 24678 females with COPD_LATER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| COPD_LATER | 2.755 [2.5, 3.04] | < 0.001 |
| Birth year | 0.986 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 33995 out of 49460 males with COPD_LATER died.
Mortality risk
Mortality risk for people of age
years, who have COPD_LATER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.323% | 0.504% |
| 5 | 1.641% | 2.552% |
| 10 | 3.845% | 6.443% |
| 15 | 7.226% | 12.572% |
| 20 | 12.606% | 20.805% |
Relationships between endpoints
↥Index endpoint: COPD_LATER – Later onset COPD
GWS hits: 7
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data